P70S6K
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A0MZ66 | S493 | Sugiyama | SHTN1 KIAA1598 | sEtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsV |
| A0MZ66 | S502 | Sugiyama | SHTN1 KIAA1598 | RRRKVtAEADsssPtGILAtsEsKsMPVLGsVssVTKTALN |
| A0MZ66 | S504 | Sugiyama | SHTN1 KIAA1598 | RKVtAEADsssPtGILAtsEsKsMPVLGsVssVTKTALNKK |
| A0MZ66 | T487 | Sugiyama | SHTN1 KIAA1598 | sLDPENsEtELERILRRRKVtAEADsssPtGILAtsEsKsM |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| O00418 | S366 | SIGNOR|ELM|iPTMNet|PSP | EEF2K | AKtILRGtEEKCGsPQVRTLsGSRPPLLRPLsENSGDENMS |
| O00512 | S104 | Sugiyama | BCL9 | GLKNGAGNGAKGKGKRERsIsADsFDQRDPGtPNDDsDIKE |
| O00571 | S606 | Sugiyama | DDX3X DBX DDX3 | GRSKssRFsGGFGARDYRQssGAssssFsssRAsSsRSGGG |
| O14734 | S315 | Sugiyama | ACOT8 ACTEIII PTE1 | DGVLAVTCAQEGVIRVKPQVsESKL________________ |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14974 | T700 | Sugiyama | PPP1R12A MBS MYPT1 | sQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRSTRTR |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15143 | S328 | Sugiyama | ARPC1B ARC41 | KAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTT |
| O15357 | S1176 | Sugiyama | INPPL1 SHIP2 | RGLPsDyGRPLsFPPPRIREsIQEDLAEEAPCLQGGRASGL |
| O15372 | S290 | Sugiyama | EIF3H EIF3S3 | QQQQKHQYQQRRQQENMQRQsRGEPPLPEEDLsKLFKPPQP |
| O15530 | S549 | SIGNOR | PDPK1 PDK1 | SGNAHKWCRKIQEVWRQRYQsHPDAAVQ_____________ |
| O43379 | S49 | Sugiyama | WDR62 C19orf14 | RGQssPPPAPPICLRRRtRLstAsEETVQNRVsLEKVLGIT |
| O43379 | S52 | Sugiyama | WDR62 C19orf14 | ssPPPAPPICLRRRtRLstAsEETVQNRVsLEKVLGITAQN |
| O43379 | T50 | Sugiyama | WDR62 C19orf14 | GQssPPPAPPICLRRRtRLstAsEETVQNRVsLEKVLGITA |
| O43390 | S428 | Sugiyama | HNRNPR HNRPR | LAKPPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRG |
| O43818 | S53 | Sugiyama | RRP9 RNU3IP2 U355K | AGDRGKSKGGGKMNEEIssDsEsEsLAPRKPEEEEEEELEE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O43847 | T59 | Sugiyama | NRDC NRD1 | SAAARPFPILAMPGRNKAKstCsCPDLQPNGQDLGENSRVA |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60264 | S137 | Sugiyama | SMARCA5 SNF2H WCRF135 | PLKMKPGRPRIKKDEKQNLLsVGDyRHRRTEQEEDEELLTE |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60331 | S555 | SIGNOR|PSP | PIP5K1C KIAA0589 | IPERSPsETSEQPRYRRRtQssGQDGRPQEEPPAEEDLQQI |
| O60331 | T553 | SIGNOR|PSP | PIP5K1C KIAA0589 | LSIPERSPsETSEQPRYRRRtQssGQDGRPQEEPPAEEDLQ |
| O60343 | S754 | Sugiyama | TBC1D4 AS160 KIAA0603 | QDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISWRQ |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60739 | T46 | Sugiyama | EIF1B | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60825 | S466 | SIGNOR | PFKFB2 | RDKPTNNFPKNQTPVRMRRNsFtPLsssNtIRRPRNYsVGs |
| O60832 | S453 | Sugiyama | DKC1 NOLA4 | KAPQVVAEAAKTAKRKREsEsEsDEtPPAAPQLIKKEKKKS |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O75030 | S409 | SIGNOR | MITF BHLHE32 | LLRIQELEMQARAHGLsLIPsTGLCsPDLVNRIIKQEPVLE |
| O75122 | S621 | Sugiyama | CLASP2 KIAA0627 | AVADALKKPARRRyEsYGMHsDDDANSDASSACSERSYSSR |
| O75122 | Y614 | Sugiyama | CLASP2 KIAA0627 | tGsDVEEAVADALKKPARRRyEsYGMHsDDDANSDASSACS |
| O75400 | S927 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | RTRQRSESKHKSPKKKtGKDsGNWDtsGsELsEGELEKRRR |
| O75400 | T923 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | SEKDRTRQRSESKHKSPKKKtGKDsGNWDtsGsELsEGELE |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O94763 | S372 | SIGNOR|PSP | URI1 C19orf2 NNX3 PPP1R19 RMP URI | KNTTLKFSEKKEEAKRKRKNstGsGHsAQELPTIRTPADIY |
| O94776 | S52 | Sugiyama | MTA2 MTA1L1 PID | KTANGNVEAKVVCLFRRRDIsssLNSLADSNAREFEEESKQ |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95239 | S801 | Sugiyama | KIF4A KIF4 | LKEKKESGENPPPKLRRRtFsLtEVRGQVsEsEDsItKQIE |
| O95249 | T55 | Sugiyama | GOSR1 GS28 | TSYSHSsTRDGRRDRYssDTtPLLNGSSQDRMFETMAIEIE |
| O95831 | S116 | Sugiyama | AIFM1 AIF PDCD8 | NERIsGLGLtPEQKQKKAALsAsEGEEVPQDKAPSHVPFLL |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P01100 | S362 | SIGNOR | FOS G0S7 | VFTYPEADSFPSCAAAHRKGsSsNEPSSDSLSsPTLLAL__ |
| P01100 | S374 | SIGNOR | FOS G0S7 | CAAAHRKGsSsNEPSSDSLSsPTLLAL______________ |
| P02545 | S437 | Sugiyama | LMNA LMN1 | KKRKLEstEsRssFsQHARtsGRVAVEEVDEEGKFVRLRNK |
| P03372 | S167 | SIGNOR|PSP | ESR1 ESR NR3A1 | PAFYRPNsDNRRQGGRERLAsTNDKGSMAMESAKETRYCAV |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S15 | SIGNOR | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S78 | SIGNOR|ELM | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | SIGNOR|ELM|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05783 | S53 | ELM | KRT18 CYK18 PIG46 | AsVyAGAGGsGsRIsVsRstsFRGGMGsGGLAtGIAGGLAG |
| P05787 | S475 | Sugiyama | KRT8 CYK8 | TSSSRAVVVKKIETRDGKLVsEssDVLPK____________ |
| P06493 | S39 | PSP | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | yKGRHKTTGQVVAMKKIRLEsEEEGVPstAIREIsLLKELR |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07814 | S1336 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | SEEDKEALIAKCNDYRRRLLsVNIRVRADLRDNysPGWKFN |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | S880 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LKAQYKEKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPE |
| P07814 | S999 | PSP | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | QKQNDGQRKDPsKNQGGGLsssGAGEGQGPKKQTRLGLEAK |
| P07814 | T745 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVR |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07942 | S1115 | Sugiyama | LAMB1 | SCNEFTGQCQCMPGFGGRTCsECQELFWGDPDVECRACDCD |
| P08151 | S84 | SIGNOR|PSP | GLI1 GLI | EGPLFSSPRSAVKLTKKRALsISPLSDASLDLQTVIRTsPS |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11274 | Y246 | Sugiyama | BCR BCR1 D22S11 | ASRPPYRGRssEssCGVDGDyEDAELNPRFLKDNLIDANGG |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P12270 | S1185 | Sugiyama | TPR | KLSDKVVASVKEGVQGPLNVsLsEEGKSQEQILEILRFIRR |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13797 | S120 | Sugiyama | PLS3 | KEGICALGGTsELssEGtQHsysEEEKyAFVNWINKALEND |
| P13861 | S58 | Sugiyama | PRKAR2A PKR2 PRKAR2 | TRLREARAPAsVLPAAtPRQsLGHPPPEPGPDRVADAKGDs |
| P13861 | S78 | Sugiyama | PRKAR2A PKR2 PRKAR2 | sLGHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | T95 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTK |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P16220 | S119 | SIGNOR | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17655 | T464 | Sugiyama | CAPN2 CANPL2 | TNIHLSKNFFLTNRARERsDtFINLREVLNRFKLPPGEYIL |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19634 | S703 | SIGNOR | SLC9A1 APNH1 NHE1 | yLtVPAHKLDsPtMsRARIGsDPLAyEPKEDLPVItIDPAs |
| P20042 | S158 | Sugiyama | EIF2S2 EIF2B | EILEKDEALEDEDNKKDDGIsFsNQtGPAWAGSERDytyEE |
| P20042 | T163 | Sugiyama | EIF2S2 EIF2B | DEALEDEDNKKDDGIsFsNQtGPAWAGSERDytyEELLNRV |
| P20810 | S366 | Sugiyama | CAST | DKDGKPLLPEPEEKPKPRsEsELIDELsEDFDRsECKEKPS |
| P21333 | S1301 | Sugiyama | FLNA FLN FLN1 | DARALtQtGGPHVKARVANPsGNLTEtyVQDRGDGMYKVEy |
| P21333 | S2152 | SIGNOR | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P22033 | S481 | Sugiyama | MMUT MUT | EGIPKLRIEECAARRQARIDsGSEVIVGVNKYQLEKEDAVE |
| P22087 | S124 | Sugiyama | FBL FIB1 FLRN | DALVTKNLVPGEsVyGEKRVsIsEGDDKIEyRAWNPFRSKL |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P23142 | S247 | Sugiyama | FBLN1 PP213 | CRLGESCINTVGSFRCQRDssCGtGYELTEDNSCKDIDECE |
| P23381 | S351 | Sugiyama | WARS1 IFI53 WARS WRS | KPALLHSTFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTK |
| P23381 | S353 | Sugiyama | WARS1 IFI53 WARS WRS | ALLHSTFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVN |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23443 | S375 | Sugiyama | RPS6KB1 STK14A | INWEELLARKVEPPFKPLLQsEEDVsQFDSKFtRQtPVDsP |
| P23443 | S380 | Sugiyama | RPS6KB1 STK14A | LLARKVEPPFKPLLQsEEDVsQFDSKFtRQtPVDsPDDstL |
| P23443 | S75 | Sugiyama | RPS6KB1 STK14A | DHGGVGPYELGMEHCEKFEIsEtsVNRGPEKIRPECFELLR |
| P23443 | S78 | Sugiyama | RPS6KB1 STK14A | GVGPYELGMEHCEKFEIsEtsVNRGPEKIRPECFELLRVLG |
| P23443 | T412 | ELM|PSP | RPS6KB1 STK14A | VDsPDDstLsEsANQVFLGFtYVAPSVLESVKEKFsFEPKI |
| P23443 | T77 | Sugiyama | RPS6KB1 STK14A | GGVGPYELGMEHCEKFEIsEtsVNRGPEKIRPECFELLRVL |
| P23443 | Y11 | Sugiyama | RPS6KB1 STK14A | __________MRRRRRRDGFyPAPDFRDREAEDMAGVFDID |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | S422 | SIGNOR|ELM|iPTMNet|PSP | EIF4B | ERHPsWRsEEtQERERsRtGsEssQtGtstTssRNARRREs |
| P24941 | T39 | Sugiyama | CDK2 CDKN2 | yKARNKLTGEVVALKKIRLDtETEGVPstAIREIsLLKELN |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25786 | S211 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | GLRALRETLPAEQDLttKNVsIGIVGKDLEFTIyDDDDVsP |
| P26038 | S440 | Sugiyama | MSN | EMAELtARIsQLEMARQKKEsEAVEWQQKAQMVQEDLEKTR |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26232 | S654 | Sugiyama | CTNNA2 CAPR | EELEDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQ |
| P26373 | S109 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | KVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILFPR |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26639 | S702 | Sugiyama | TARS1 TARS | ISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAEEE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27540 | S271 | Sugiyama | ARNT BHLHE2 | SSMRMCMGSRRSFICRMRCGsSSVDPVSVNRLSFVRNRCRN |
| P27708 | S1859 | SIGNOR|PSP|Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30304 | S293 | SIGNOR | CDC25A | LKRPERsQEEsPPGSTKRRKsMsGASPKESTNPEKAHETLH |
| P30304 | S295 | SIGNOR | CDC25A | RPERsQEEsPPGSTKRRKsMsGASPKESTNPEKAHETLHQS |
| P30305 | S353 | SIGNOR | CDC25B CDC25HU2 | LKRLERPQDRDTPVQNKRRRsVtPPEEQQEAEEPKARVLRs |
| P30305 | T355 | SIGNOR | CDC25B CDC25HU2 | RLERPQDRDTPVQNKRRRsVtPPEEQQEAEEPKARVLRsKs |
| P30533 | S137 | Sugiyama | LRPAP1 A2MRAP | VILAKYGLDGKKDARQVtsNsLsGtQEDGLDDPRLEKLWHK |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P31327 | S896 | Sugiyama | CPS1 | WFLYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQ |
| P32004 | S1152 | SIGNOR | L1CAM CAML1 MIC5 | LLLLVLLILCFIKRSKGGKysVKDKEDtQVDsEARPMKDEt |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32969 | S135 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | RNFLGEKYIRRVRMRPGVACsVsQAQKDELILEGNDIELVS |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S647 | Sugiyama | HSPA4 APG2 HSPH2 | EMRDKLSGEYEKFVSEDDRNsFtLKLEDTENWLyEDGEDQP |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35221 | S655 | Sugiyama | CTNNA1 | PEELDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQ |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35568 | S1101 | SIGNOR|PSP | IRS1 | RNQSAKVIRADPQGCRRRHssEtFsstPSATRVGNTVPFGA |
| P35568 | S270 | SIGNOR|PSP | IRS1 | HETILEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHHLN |
| P35568 | S307 | SIGNOR|PSP | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P35568 | S527 | SIGNOR|PSP | IRS1 | AGDEAASAADLDNRFRKRtHsAGtsPTITHQKTPSQSSVAs |
| P35568 | S636 | SIGNOR|PSP | IRS1 | sPGVAPVPSGRKGsGDyMPMsPKsVSAPQQIINPIRRHPQR |
| P35568 | S639 | SIGNOR | IRS1 | VAPVPSGRKGsGDyMPMsPKsVSAPQQIINPIRRHPQRVDP |
| P35659 | S301 | Sugiyama | DEK | NVKKADSSTTKKNQNSSKKEsEsEDssDDEPLIKKLKKPPT |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36578 | Y52 | Sugiyama | RPL4 RPL1 | IRPDIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRA |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P41567 | T46 | Sugiyama | EIF1 SUI1 | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| P42224 | S708 | Sugiyama | STAT1 | PEPMELDGPKGtGyIKtELIsVsEVHPSRLQttDNLLPMsP |
| P42345 | S2448 | SIGNOR|ELM|iPTMNet|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | NWRLMDTNTKGNKRsRtRtDsYsAGQsVEILDGVELGEPAH |
| P42345 | T2446 | SIGNOR|ELM|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | LLNWRLMDTNTKGNKRsRtRtDsYsAGQsVEILDGVELGEP |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S185 | Sugiyama | RPL5 MSTP030 | GAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRKHIMGQNVA |
| P46777 | S187 | Sugiyama | RPL5 MSTP030 | VDGGLsIPHstKRFPGyDsEsKEFNAEVHRKHIMGQNVADy |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46779 | T75 | Sugiyama | RPL28 | ADGKGVVVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRH |
| P46779 | T81 | Sugiyama | RPL28 | VVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKNK |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S706 | Sugiyama | NASP | GGGssVsMIASRKPtDGAsssNCVTDIsHLVRKKRKPEEEs |
| P49321 | T700 | Sugiyama | NASP | sGFtPGGGGssVsMIASRKPtDGAsssNCVTDIsHLVRKKR |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49589 | S305 | Sugiyama | CARS1 CARS | KLVPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKA |
| P49591 | S394 | Sugiyama | SARS1 SARS SERS | SKKLDLEAWFPGSGAFRELVsCSNCTDyQARRLRIRYGQTK |
| P49753 | T118 | Sugiyama | ACOT2 PTE2 PTE2A | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| P49815 | S1798 | SIGNOR | TSC2 TSC4 | AQTPAEPTPGyEVGQRKRLIssVEDFTEFV___________ |
| P49841 | S9 | SIGNOR|PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P49959 | T597 | SIGNOR|PSP | MRE11 HNGS1 MRE11A | RGGRGQNSASRGGsQRGRADtGLETSTRSRNSKTAVSASRN |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50549 | S191 | SIGNOR | ETV1 ER81 | PSQSIPDSSYPMDHRFRRQLsEPCNSFPPLPTMPREGRPMY |
| P50549 | S216 | SIGNOR | ETV1 ER81 | SFPPLPTMPREGRPMYQRQMsEPNIPFPPQGFKQEYHDPVY |
| P50552 | T278 | SIGNOR | VASP | SGGGGLMEEMNAMLARRRKAtQVGEKtPKDEsANQEEPEAR |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P51858 | S107 | Sugiyama | HDGF HMG1L2 | WEIENNPtVKASGYQSsQKKsCVEEPEPEPEAAEGDGDKKG |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P52701 | S309 | PSP | MSH6 GTBP | GLNsPVKVARKRKRMVTGNGsLKRKSSRKETPSATKQAtsI |
| P52907 | T217 | Sugiyama | CAPZA1 | HYYEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENAEN |
| P52948 | S683 | Sugiyama | NUP98 ADAR2 | IAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEG |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S457 | Sugiyama | ACLY | FLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMPQD |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P53999 | S9 | Sugiyama | SUB1 PC4 RPO2TC1 | ____________MPKSKELVsssssGsDsDsEVDKKLKRKK |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55036 | T264 | Sugiyama | PSMD4 MCB1 | AEAGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEE |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55957 | S76 | Sugiyama | BID | ELQtDGNRssHsRLGRIEADsEsQEDIIRNIARHLAQVGDs |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60468 | S49 | Sugiyama | SEC61B | STVRQRKNASCGTRSAGRtTsAGTGGMWRFYTEDSPGLKVG |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60983 | T27 | Sugiyama | GMFB | VCDVAEDLVEKLRKFRFRKEtNNAAIIMKIDKDKRLVVLDE |
| P61024 | S39 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | yRHVMLPKDIAKLVPKTHLMsEsEWRNLGVQQsQGWVHyMI |
| P61158 | S406 | Sugiyama | ACTR3 ARP3 | STPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61769 | T106 | Sugiyama | B2M CDABP0092 HDCMA22P | YYTEFTPTEKDEYACRVNHVtLsQPKIVKWDRDM_______ |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62081 | T121 | Sugiyama | RPS7 | LPKPTRKSRTKNKQKRPRsRtLtAVHDAILEDLVFPsEIVG |
| P62081 | T123 | Sugiyama | RPS7 | KPTRKSRTKNKQKRPRsRtLtAVHDAILEDLVFPsEIVGKR |
| P62241 | S4 | Sugiyama | RPS8 OK/SW-cl.83 | _________________MGIsRDNWHKRRKTGGKRKPYHKK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62633 | S47 | Sugiyama | CNBP RNF163 ZNF9 | RGMRSRGRGGFTSDRGFQFVsSSLPDICYRCGESGHLAKDC |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62753 | S235 | SIGNOR|ELM|PSP | RPS6 OK/SW-cl.2 | KRMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK______ |
| P62753 | S236 | SIGNOR|ELM|PSP | RPS6 OK/SW-cl.2 | RMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK_______ |
| P62753 | S240 | SIGNOR|PSP | RPS6 OK/SW-cl.2 | AKEKRQEQIAKRRRLssLRAstsKsEssQK___________ |
| P62753 | S244 | SIGNOR|PSP | RPS6 OK/SW-cl.2 | RQEQIAKRRRLssLRAstsKsEssQK_______________ |
| P62753 | T34 | Sugiyama | RPS6 OK/SW-cl.2 | KLIEVDDERKLRtFyEKRMAtEVAADALGEEWKGYVVRIsG |
| P62805 | S48 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | QGItKPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIR |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P67809 | S102 | SIGNOR|Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68431 | T59 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| P78362 | S494 | SIGNOR|PSP|Sugiyama | SRPK2 | GSPLTEQEESSPSHDRSRtVsAsstGDLPKAKTRAADLLVN |
| P78371 | S143 | Sugiyama | CCT2 99D8.1 CCTB | PQTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIA |
| P78371 | S260 | SIGNOR|PSP | CCT2 99D8.1 CCTB | ANtGMDtDKIKIFGsRVRVDstAKVAEIEHAEKEKMKEKVE |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84243 | S11 | SIGNOR | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | __________MARtKQTARKstGGKAPRKQLATKAARKsAP |
| P84243 | T59 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| P98175 | S797 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | HQQLsGLHKQNLEIHRRAHLsENELEALEKNDMEQMKYRDR |
| P99999 | S48 | Sugiyama | CYCS CYC | KTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEY |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02818 | S193 | Sugiyama | NUCB1 NUC | HEEFKRyEMLKEHERRRyLEsLGEEQRKEAERKLEEQQRRH |
| Q04837 | S67 | Sugiyama | SSBP1 SSBP | QVEGKNPVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRI |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q05195 | S145 | SIGNOR|PSP | MXD1 MAD | EQRHLKRQLEKLGIERIRMDsIGSTVSSERSDSDREEIDVD |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q05655 | S302 | Sugiyama | PRKCD PKCD | INQKLLAEALNQVtQRAsRRsDsAssEPVGIyQGFEKKTGV |
| Q06787 | S500 | PSP | FMR1 | GHGRRGPGYTSGTNSEAsNAsEtEsDHRDELsDWSLAPTEE |
| Q06830 | S30 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | HPAPNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTF |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07157 | S1063 | Sugiyama | TJP1 ZO1 | LPYVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDR |
| Q07864 | S1297 | Sugiyama | POLE POLE1 | KKWQLQARQRLARRKRQRLEsAEGVLRPGAIRDGPATGLGs |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q08211 | S452 | Sugiyama | DHX9 DDX9 LKP NDH2 | NDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSCGYS |
| Q08378 | S465 | Sugiyama | GOLGA3 | LSTKLQAQVECSHSSQQRQDsLsSEVDTLKQsCWDLERAMT |
| Q08945 | S657 | Sugiyama | SSRP1 FACT80 | MEKKSTPSRGsSSKSsSRQLsEsFKSKEFVssDEsssGENK |
| Q09161 | S22 | PSP|Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09161 | S7 | PSP | NCBP1 CBP80 NCBP | ______________MSRRRHsDENDGGQPHKRRKtsDANEt |
| Q09161 | T21 | PSP | NCBP1 CBP80 NCBP | MSRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEK |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q12824 | S111 | Sugiyama | SMARCB1 BAF47 INI1 SNF5L1 | LKASEVEEILDGNDEKYKAVsISTEPPTYLREQKAKRNsQW |
| Q12965 | T939 | Sugiyama | MYO1E MYO1C | SIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPP |
| Q12965 | Y941 | Sugiyama | MYO1E MYO1C | GPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGy |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13247 | S301 | Sugiyama | SRSF6 SFRS6 SRP55 | PKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKR |
| Q13286 | S12 | Sugiyama | CLN3 BTS | _________MGGCAGSRRRFsDsEGEEtVPEPRLPLLDHQG |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13428 | S85 | Sugiyama | TCOF1 | AEEDAALQAKKTRVsDPIstsEssEEEEEAEAETAKAtPRL |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13501 | S24 | Sugiyama | SQSTM1 ORCA OSIL | LTVKAYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPC |
| Q13561 | S83 | Sugiyama | DCTN2 DCTN50 | GTKGLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKY |
| Q13765 | S117 | Sugiyama | NACA HSD48 | RKSKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQL |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S895 | Sugiyama | EIF3A EIF3S10 KIAA0139 | ERRLGDssLSRKDSRWGDRDsEGtWRKGPEADsEWRRGPPE |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14153 | S167 | Sugiyama | FAM53B KIAA0140 SMP | YsGGsVQRYSNGFSTMQRsssFSLPSRANVLssPCDQAGLH |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14697 | S187 | Sugiyama | GANAB G2AN KIAA0088 | LLsVNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRD |
| Q14697 | S190 | Sugiyama | GANAB G2AN KIAA0088 | VNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRDGDK |
| Q14978 | S85 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | ERKLQANGPVAKKAKKKAsssDsEDssEEEEEVQGPPAKKA |
| Q15020 | S650 | Sugiyama | SART3 KIAA0156 TIP110 | EKEWGDDEEEQPSKRRRVENsIPAAGETQNVEVAAGPAGKC |
| Q15084 | S375 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GYPAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGst |
| Q15149 | S4386 | Sugiyama | PLEC PLEC1 | ItEFADMLsGNAGGFRsRsssVGssssyPIsPAVsRtQLAs |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15428 | S153 | Sugiyama | SF3A2 SAP62 | LFQIDYPEIAEGIMPRHRFMsAyEQRIEPPDRRWQYLLMAA |
| Q15633 | S283 | SIGNOR|PSP | TARBP2 TRBP | CTWDSLRNSVGEKILSLRsCsLGsLGALGPACCRVLSELSE |
| Q15633 | S286 | SIGNOR | TARBP2 TRBP | DSLRNSVGEKILSLRsCsLGsLGALGPACCRVLSELSEEQA |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15831 | S428 | SIGNOR|iPTMNet | STK11 LKB1 PJS | GRAPNPARKACSASSKIRRLsACKQQ_______________ |
| Q16181 | T318 | Sugiyama | SEPTIN7 CDC10 SEPT7 | KDVTNNVHyENyRSRKLAAVtyNGVDNNKNKGQLtKsPLAQ |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16637 | S49 | PSP | SMN1 SMN SMNT; SMN2 SMNC | DDsDIWDDtALIKAYDKAVAsFKHALKNGDICETsGKPKtt |
| Q16695 | T59 | Sugiyama | H3-4 H3FT HIST3H3 | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLMREIAQDF |
| Q16763 | T152 | Sugiyama | UBE2S E2EPF OK/SW-cl.73 | EAGRLLLENyEEyAARARLLtEIHGGAGGPSGRAEAGRALA |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q16821 | S46 | SIGNOR | PPP1R3A PP1G | CEDEEVTFQPGFSPQPSRRGsDsSEDIYLDTPSSGTRRVsF |
| Q16873 | S36 | SIGNOR|PSP | LTC4S | VLLQAYFSLQVISARRAFRVsPPLtTGPPEFERVYRAQVNC |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3B726 | S316 | Sugiyama | POLR1F TWISTNB | GsDssGyQsDHKKKKKKRKHsEEAEFtPPLKCsPKRKGKSN |
| Q3KQU3 | S112 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | KsRGPtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEV |
| Q4G0J3 | S258 | Sugiyama | LARP7 HDCMA18P | EENMDtsNtsIsKMKRsRPtsEGsDIEstEPQKQCSKKKKK |
| Q4G0J3 | S300 | Sugiyama | LARP7 HDCMA18P | DRVEAssLPEVRTGKRKRsssEDAEsLAPRSKVKKIIQKDI |
| Q53EL6 | S457 | PSP | PDCD4 H731 | GIISKQLRDLCPSRGRKRFVsEGDGGRLKPESY________ |
| Q53EL6 | S67 | SIGNOR|PSP | PDCD4 H731 | AssINEARINAKAKRRLRKNssRDsGRGDsVsDsGsDALRS |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5TKA1 | S177 | Sugiyama | LIN9 BARA TGS | KLTRVEWGKIRRLMGKPRRCssAFFEEERSALKQKRQKIRL |
| Q5TKA1 | S178 | Sugiyama | LIN9 BARA TGS | LTRVEWGKIRRLMGKPRRCssAFFEEERSALKQKRQKIRLL |
| Q5VT52 | S1070 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETLGy |
| Q5VTB9 | T368 | Sugiyama | RNF220 C1orf164 | ENNNRFEEYEWCGQKRIRATtLLEGGFRGSGFIMCSGKENP |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6NXT2 | T58 | Sugiyama | H3-5 H3F3C | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| Q6R327 | T1135 | SIGNOR|PSP | RICTOR KIAA1999 | PKGGKLSSESKTSNRRIRtLtEPsVDFNHsDDFtPISTVQK |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71DI3 | T59 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | PHRyRPGtVALREIRRYQKstELLIRKLPFQRLVREIAQDF |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | T685 | Sugiyama | NUFIP2 KIAA1321 PIG1 | HTKEMEsIWNLQKQDPKRIItyNEAMDsPDQ__________ |
| Q7Z417 | Y686 | Sugiyama | NUFIP2 KIAA1321 PIG1 | TKEMEsIWNLQKQDPKRIItyNEAMDsPDQ___________ |
| Q7Z4V5 | S369 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EKERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGR |
| Q7Z4V5 | S395 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | REDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKK |
| Q7Z4V5 | S397 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | DDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKPQ |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q86T24 | T606 | PSP | ZBTB33 KAISO ZNF348 | LHPCRSLQIRQYAYLSDRSStIPAMKDDGIGYKVDTGKEPP |
| Q86TX2 | T56 | Sugiyama | ACOT1 CTE1 | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| Q86UE4 | S494 | Sugiyama | MTDH AEG1 LYRIC | PVNtsKTRPKQEKAFSLKtIstsDPAEVLVKNSQPIKTLPP |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86VM9 | S603 | Sugiyama | ZC3H18 NHN1 | SSRSSRHSSFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKG |
| Q86VM9 | T395 | Sugiyama | ZC3H18 NHN1 | EIERFWRGGQyENFRVQYtEtEPyHNYRERERERERENRQR |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86X55 | T39 | Sugiyama | CARM1 PRMT4 | VPGGAGPCATVSVFPGARLLtIGDANGEIQRHAEQQALRLE |
| Q8IWW6 | S215 | Sugiyama | ARHGAP12 | QEQSCDSAGEGSERIHQDSEsGDELSSSsTEQIRAttPPNQ |
| Q8IWX8 | S817 | Sugiyama | CHERP DAN26 SCAF6 | QSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDS |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8IX03 | S947 | SIGNOR | WWC1 KIAA0869 KIBRA | sKtFsPGPQSQYVCRLNRsDsDsSTLSKKPPFVRNSLERRS |
| Q8IX03 | T929 | SIGNOR | WWC1 KIAA0869 KIBRA | RVGtPsQGPFLRGSTIIRsKtFsPGPQSQYVCRLNRsDsDs |
| Q8N122 | S719 | SIGNOR | RPTOR KIAA1303 RAPTOR | TTEGGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSL |
| Q8N122 | S721 | SIGNOR | RPTOR KIAA1303 RAPTOR | EGGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSLQN |
| Q8N122 | S722 | SIGNOR | RPTOR KIAA1303 RAPTOR | GGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSLQNL |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q8N6T3 | S348 | Sugiyama | ARFGAP1 ARF1GAP | FWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWG |
| Q8NE71 | S285 | Sugiyama | ABCF1 ABC50 | MEYERQVASLKAANAAENDFsVsQAEMSsRQAMLENASDIK |
| Q8NEJ9 | S202 | Sugiyama | NGDN C14orf120 | DETEAEREKKRLERAKRRALsSsVIRELKEQYsDAPEEIRD |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TB45 | S286 | SIGNOR|PSP | DEPTOR DEPDC6 | PsKEIKIVSAVRRssMssCGssGyFsssPtLsssPPVLCNP |
| Q8TB45 | S287 | SIGNOR|PSP | DEPTOR DEPDC6 | sKEIKIVSAVRRssMssCGssGyFsssPtLsssPPVLCNPK |
| Q8TB45 | S291 | SIGNOR|PSP | DEPTOR DEPDC6 | KIVSAVRRssMssCGssGyFsssPtLsssPPVLCNPKSVLK |
| Q8TD19 | T333 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | REMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWG |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TEQ6 | S852 | Sugiyama | GEMIN5 | PKEKPETLIKKRKARsLLPLstsLDHRSKEELHQDCLVLAT |
| Q8TEW0 | S837 | Sugiyama | PARD3 PAR3 PAR3A | AFQREGFGRQsMsEKRtKQFsDAsQLDFVKTRKsKsMDLGI |
| Q8TEW0 | S962 | Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q8TEW0 | Y719 | Sugiyama | PARD3 PAR3 PAR3A | PELPIETALDDRERRIsHsLysGIEGLDEsPsRNAALsRIM |
| Q8WUA7 | S150 | Sugiyama | TBC1D22A C22orf4 | PPsPPsGDLRLVKsVsEsHtsCPAESASDAAPLQRsQsLPH |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q92519 | S83 | SIGNOR|PSP | TRIB2 TRB2 | KYLLLEPLEGDHVFRAVHLHsGEELVCKVFDISCYQESLAP |
| Q92570 | S376 | SIGNOR | NR4A3 CHN CSMF MINOR NOR1 TEC | GMVKEVVRTDsLKGRRGRLPsKPKsPLQQEPsQPsPPsPPI |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92614 | S1465 | Sugiyama | MYO18A CD245 KIAA0216 MYSPDZ TIAF1 | HLEGQQVRNHELEKKQRRFDsELSQAHEEAQREKLQREKLQ |
| Q92934 | S118 | SIGNOR | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S153 | SIGNOR | BAD BBC6 BCL2L8 | KsAGtATQMRQSSSWTRVFQsWWDRNLGRGSSAPSQ_____ |
| Q92934 | S75 | SIGNOR | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92945 | S395 | PSP | KHSRP FUBP2 | PPDRCEHAARIINDLLQSLRsGPPGPPGGPGMPPGGRGRGR |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q969S3 | S38 | Sugiyama | ZNF622 ZPR9 | MQRAHYKTDWHRYNLRRKVAsMAPVTAEGFQERVRAQRAVA |
| Q96CW6 | T177 | Sugiyama | SLC7A6OS | KTSDPDVILCNsVELIRERLtVSEDGPGVRRQEEQKHDDYV |
| Q96DV4 | S129 | Sugiyama | MRPL38 HSPC262 | AIQELRANVEEERAARLRTAsVPLDAVRAEWERTCGPYHKQ |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96GM8 | S420 | Sugiyama | TOE1 | KNDLEMGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRA |
| Q96GM8 | S425 | Sugiyama | TOE1 | MGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRAGFDAF |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96JP5 | S177 | Sugiyama | ZFP91 ZNF757 FKSG11 | TSVSRHRDTENTRSSRSKTGsLQLICKSEPNTDQLDYDVGE |
| Q96KQ7 | S232 | Sugiyama | EHMT2 BAT8 C6orf30 G9A KMT1C NG36 | DDVHsLGKVTSDLAKRRKLNsGGGLsEELGsARRsGEVTLt |
| Q96PZ0 | S53 | Sugiyama | PUS7 KIAA1897 | QKLsECsLTKGQDGLQNDFLsISEDVPRPPDtVStGKGGKN |
| Q96RU3 | S497 | Sugiyama | FNBP1 FBP17 KIAA0554 | AWLAEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREs |
| Q99426 | T108 | Sugiyama | TBCB CG22 CKAP1 | IDHsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKRs |
| Q99543 | S47 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | QVEPVGRWFEAFVKRRNRNAsAsFQELEDKKELsEEsEDEE |
| Q99543 | S49 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | EPVGRWFEAFVKRRNRNAsAsFQELEDKKELsEEsEDEELQ |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q9BQ52 | S215 | Sugiyama | ELAC2 HPC2 | QPWQsPERPLsRLsPERssDsEsNENEPHLPHGVsQRRGVR |
| Q9BQG0 | S1186 | Sugiyama | MYBBP1A P160 | sKKRKKKGFLPETKKRKKRKsEDGtPAEDGtPAATGGsQPP |
| Q9BRS2 | S498 | Sugiyama | RIOK1 RIO1 | GVQKVPALLENQVEERtCsDsEDIGssECsDtDSEEQGDHA |
| Q9BRS2 | S503 | Sugiyama | RIOK1 RIO1 | PALLENQVEERtCsDsEDIGssECsDtDSEEQGDHARPKKH |
| Q9BRS2 | S504 | Sugiyama | RIOK1 RIO1 | ALLENQVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHT |
| Q9BVJ6 | S29 | Sugiyama | UTP14A SDCCAG16 | sLLALsQQEELADLPKDyLLsEsEDEGDNDGERKHQKLLEA |
| Q9BVS4 | S335 | Sugiyama | RIOK2 RIO2 | LLHPLGPDDKNIETKEGsEFsFsDGEVAEKAEVyGsENEsE |
| Q9BVS4 | S412 | Sugiyama | RIOK2 RIO2 | EMTEFNQALEEIKGQVVENNsVTEFsEEKNRTENYNRQDGQ |
| Q9BY44 | S524 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | DKsPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKL |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BY44 | T522 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | RsDKsPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKK |
| Q9BY77 | S383 | SIGNOR|ELM|PSP | POLDIP3 KIAA1649 PDIP46 | LRLSDsPsMKKESELPRRVNsAsssNPPAEVDPDTILKALF |
| Q9BY77 | S385 | SIGNOR|PSP | POLDIP3 KIAA1649 PDIP46 | LSDsPsMKKESELPRRVNsAsssNPPAEVDPDTILKALFKs |
| Q9BYV9 | S520 | PSP | BACH2 | CPVPIKVCPRsPPLETRTRTssSCSSYSYAEDGSGGSPCSL |
| Q9BYV9 | S521 | PSP | BACH2 | PVPIKVCPRsPPLETRTRTssSCSSYSYAEDGSGGSPCSLP |
| Q9BYX2 | S915 | Sugiyama | TBC1D2 PARIS1 PP8997 TBC1D2A | ELEQLKAEyLERRASRRRAVsEGCAsEDEVEGEA_______ |
| Q9BYX2 | S920 | Sugiyama | TBC1D2 PARIS1 PP8997 TBC1D2A | KAEyLERRASRRRAVsEGCAsEDEVEGEA____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9GZR1 | T1092 | Sugiyama | SENP6 KIAA0797 SSP1 SUSP1 FKSG6 | RNIILKLQEDQSKEKRKHKDtYSTEAPLGEGTEQYVNSIsD |
| Q9GZT9 | S125 | PSP | EGLN1 C1orf12 PNAS-118 PNAS-137 | GDAAKGKVKAKPPADPAAAAsPCRAAAGGQGsAVAAEAEPG |
| Q9H0H5 | S206 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | tsRQFVDGPPGPVKKtRsIGsAVDQGNEsIVAKTTVTVPND |
| Q9H2G2 | S1210 | Sugiyama | SLK KIAA0204 STK2 | EEEFARKLQEQEVFFKMTGEsECLNPStQsRISKFyPIPsL |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H3D4 | S477 | SIGNOR | TP63 KET P63 P73H P73L TP73L | ssYGNssPPLNKMNSMNKLPsVsQLINPQQRNALtPTTIPD |
| Q9H3D4 | S560 | SIGNOR|PSP | TP63 KET P63 P73H P73L TP73L | PPPYPTDCSIVSFLARLGCSsCLDYFTTQGLTTIYQIEHYS |
| Q9H3D4 | T491 | SIGNOR | TP63 KET P63 P73H P73L TP73L | SMNKLPsVsQLINPQQRNALtPTTIPDGMGANIPMMGTHMP |
| Q9H3N1 | S226 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | LCPSKRRRPQPYPYPSKKLLsEsAQPLKKVEEEQEADEEDV |
| Q9H3Q1 | S311 | Sugiyama | CDC42EP4 BORG4 CEP4 | PsPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPDRA |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H6Z4 | S126 | SIGNOR|Sugiyama | RANBP3 | EDsDREDGNyCPPVKRERtssLtQFPPSQSEERSSGFRLKP |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S123 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | SSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLNQT |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9NP61 | S367 | Sugiyama | ARFGAP3 ARFGAP1 | DsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKDT |
| Q9NPG3 | S173 | Sugiyama | UBN1 | LTTKYGGFYINSGTLQFRQAsEsEDDFIKEKKKKSPKKRKL |
| Q9NPI1 | S336 | Sugiyama | BRD7 BP75 CELTIX1 | EQLDRIVKESGGKLTRRLVNsQCEFERRKPDGTTTLGLLHP |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NR30 | S706 | Sugiyama | DDX21 | PTASVTEIQEKWHDSRRWQLsVATEQPELEGPREGYGGFRG |
| Q9NR45 | S253 | Sugiyama | NANS SAS | KVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVERAL |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NTI5 | S1257 | Sugiyama | PDS5B APRIN AS3 KIAA0979 | LVQEQKPKGSQRSRKRGHtAsEsDEQQWPEEKRLKEDILEN |
| Q9NVN8 | S87 | Sugiyama | GNL3L | MREKQQAAREQERQKRRTIEsYCQDVLRRQEEFEHKEEVLQ |
| Q9NYF8 | S196 | Sugiyama | BCLAF1 BTF KIAA0164 | EsPLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsGDIWPGL |
| Q9NZN5 | S1288 | Sugiyama | ARHGEF12 KIAA0382 LARG | GLTEKsVQEDWQHFPRyRtAsQGPQtDSVIQNSENIKAyHs |
| Q9NZN5 | T1293 | Sugiyama | ARHGEF12 KIAA0382 LARG | sVQEDWQHFPRyRtAsQGPQtDSVIQNSENIKAyHsGEGHM |
| Q9NZN5 | Y1284 | Sugiyama | ARHGEF12 KIAA0382 LARG | VQQLGLTEKsVQEDWQHFPRyRtAsQGPQtDSVIQNSENIK |
| Q9P258 | S45 | Sugiyama | RCC2 KIAA1470 TD60 | PRKRGGPAGRKRERPERCssssGGGssGDEDGLELDGAPGG |
| Q9UBP6 | S27 | SIGNOR|Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UBT2 | T156 | Sugiyama | UBA2 SAE2 UBLE1B HRIHFB2115 | LIESGTAGYLGQVTTIKKGVtECyECHPKPTQRTFPGCtIR |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UHI6 | T748 | Sugiyama | DDX20 DP103 GEMIN3 | SQRAKQSRRNLPRRSsFRLQtEAQEDDWyDCHREIRLSFSD |
| Q9UHI8 | S607 | Sugiyama | ADAMTS1 KIAA1346 METH1 | DNPVPKNGGKYCEGKRVRYRsCNLEDCPDNNGKTFREEQCE |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKV3 | S240 | Sugiyama | ACIN1 ACINUS KIAA0670 | KPRKGERRSSRVRQARAAKLsEGsQPAEEEEDQEtPsRNLR |
| Q9UKV3 | S990 | Sugiyama | ACIN1 ACINUS KIAA0670 | KVTLGDtLtRRsIsQQKsGVsITIDDPVRtAQVPsPPRGKI |
| Q9UN36 | S332 | PSP|Sugiyama | NDRG2 KIAA1248 SYLD | QGMGYMASSCMTRLsRsRtAsLtsAAsVDGNRsRsRtLsQs |
| Q9UN36 | S350 | PSP | NDRG2 KIAA1248 SYLD | tAsLtsAAsVDGNRsRsRtLsQssEsGtLsSGPPGHTMEVS |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S1542 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDss |
| Q9UQ35 | S1653 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTARRGsR |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2V2 | S52 | SIGNOR | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.340231e-10 | 9.476 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.945614e-09 | 8.002 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.738343e-08 | 7.563 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.579224e-08 | 7.589 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.270170e-08 | 7.485 | 1 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.959380e-08 | 7.402 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.320673e-07 | 6.879 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.311426e-07 | 6.882 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.281135e-07 | 6.642 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.416209e-07 | 6.355 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.799441e-07 | 6.319 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.998792e-07 | 6.155 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.271205e-07 | 6.138 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.312114e-07 | 6.080 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.414288e-06 | 5.849 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.795749e-06 | 5.554 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.631862e-06 | 5.580 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.968960e-06 | 5.527 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.476155e-06 | 5.349 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.380114e-06 | 5.195 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.976547e-06 | 5.047 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.071807e-05 | 4.970 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.378513e-05 | 4.861 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.430746e-05 | 4.844 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.516697e-05 | 4.819 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.641083e-05 | 4.785 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.045364e-05 | 4.689 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.077156e-05 | 4.683 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.170025e-05 | 4.664 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.429159e-05 | 4.615 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.826450e-05 | 4.549 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.864663e-05 | 4.543 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.040383e-05 | 4.517 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.530935e-05 | 4.452 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.547644e-05 | 4.450 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.813632e-05 | 4.419 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.926286e-05 | 4.406 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.969856e-05 | 4.401 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.998708e-05 | 4.398 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.911045e-05 | 4.309 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.204736e-05 | 4.284 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.076354e-05 | 4.216 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.987279e-05 | 4.156 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.987279e-05 | 4.156 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.327778e-05 | 4.135 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.669940e-05 | 4.015 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.779761e-05 | 4.010 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.120965e-04 | 3.950 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.199412e-04 | 3.921 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.190764e-04 | 3.924 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.262484e-04 | 3.899 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.340242e-04 | 3.873 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.383114e-04 | 3.859 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.475479e-04 | 3.831 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.547574e-04 | 3.810 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.651605e-04 | 3.782 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.683035e-04 | 3.774 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.811336e-04 | 3.742 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.811336e-04 | 3.742 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.741788e-04 | 3.759 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.754034e-04 | 3.756 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.909491e-04 | 3.719 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.924012e-04 | 3.716 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.006810e-04 | 3.697 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.208849e-04 | 3.656 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.270984e-04 | 3.644 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.544522e-04 | 3.594 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.555376e-04 | 3.593 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.691378e-04 | 3.570 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.821169e-04 | 3.550 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.344770e-04 | 3.476 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.487439e-04 | 3.457 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.102661e-04 | 3.387 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.303607e-04 | 3.366 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.843446e-04 | 3.315 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.116784e-04 | 3.291 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.105117e-04 | 3.292 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.416962e-04 | 3.266 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.720474e-04 | 3.243 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.987593e-04 | 3.223 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.715688e-04 | 3.243 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.993314e-04 | 3.222 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.130192e-04 | 3.213 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.530836e-04 | 3.069 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.856222e-04 | 3.053 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.020714e-03 | 2.991 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.191153e-03 | 2.924 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.187620e-03 | 2.925 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.165966e-03 | 2.933 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.232468e-03 | 2.909 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.341265e-03 | 2.872 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.484695e-03 | 2.828 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.466050e-03 | 2.834 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.409573e-03 | 2.851 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.551045e-03 | 2.809 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.561027e-03 | 2.807 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.652757e-03 | 2.782 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.664266e-03 | 2.779 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.765703e-03 | 2.753 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.782604e-03 | 2.749 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.782604e-03 | 2.749 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.816699e-03 | 2.741 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.924557e-03 | 2.716 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.993577e-03 | 2.700 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.022890e-03 | 2.694 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.310775e-03 | 2.636 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.197074e-03 | 2.658 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.177200e-03 | 2.662 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.316351e-03 | 2.635 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.400181e-03 | 2.620 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.577086e-03 | 2.589 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.684441e-03 | 2.571 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.720956e-03 | 2.565 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.154594e-03 | 2.501 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.154594e-03 | 2.501 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.482551e-03 | 2.458 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.409296e-03 | 2.467 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.832871e-03 | 2.416 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.900432e-03 | 2.409 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.961263e-03 | 2.402 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.961263e-03 | 2.402 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.961263e-03 | 2.402 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.231961e-03 | 2.373 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.382957e-03 | 2.358 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.456137e-03 | 2.351 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.838138e-03 | 2.315 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.753838e-03 | 2.323 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.846550e-03 | 2.315 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.921302e-03 | 2.308 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.106411e-03 | 2.292 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.116844e-03 | 2.291 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.183338e-03 | 2.285 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.227251e-03 | 2.282 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.636737e-03 | 2.249 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.834650e-03 | 2.234 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.757321e-03 | 2.240 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.037308e-03 | 2.219 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.417195e-03 | 2.193 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.600501e-03 | 2.180 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.914920e-03 | 2.160 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.090143e-03 | 2.149 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.256943e-03 | 2.139 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.265082e-03 | 2.139 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 8.366540e-03 | 2.077 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.301979e-03 | 2.081 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.239827e-03 | 2.084 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.857631e-03 | 2.105 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.170063e-03 | 2.088 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.557493e-03 | 2.068 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.570631e-03 | 2.019 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.570631e-03 | 2.019 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.254190e-03 | 2.034 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.323858e-03 | 2.030 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.647623e-03 | 2.016 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 9.690502e-03 | 2.014 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.690502e-03 | 2.014 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.760086e-03 | 2.011 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.091634e-02 | 1.962 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.091634e-02 | 1.962 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.122654e-02 | 1.950 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.131933e-02 | 1.946 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.131933e-02 | 1.946 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.179890e-02 | 1.928 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.181225e-02 | 1.928 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.247289e-02 | 1.904 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.247289e-02 | 1.904 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.270229e-02 | 1.896 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.330102e-02 | 1.876 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.386881e-02 | 1.858 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.381900e-02 | 1.860 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.390133e-02 | 1.857 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.422601e-02 | 1.847 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.443631e-02 | 1.841 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.490018e-02 | 1.827 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.492530e-02 | 1.826 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.534212e-02 | 1.814 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.616030e-02 | 1.792 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.616030e-02 | 1.792 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.616030e-02 | 1.792 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.576603e-02 | 1.802 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.653128e-02 | 1.782 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.750474e-02 | 1.757 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.688408e-02 | 1.773 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.663152e-02 | 1.779 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.750474e-02 | 1.757 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.616030e-02 | 1.792 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.649797e-02 | 1.783 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.674290e-02 | 1.776 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.674290e-02 | 1.776 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.671028e-02 | 1.777 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.638566e-02 | 1.786 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.638566e-02 | 1.786 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.648300e-02 | 1.783 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.783009e-02 | 1.749 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.834806e-02 | 1.736 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.858201e-02 | 1.731 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.859311e-02 | 1.731 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.995835e-02 | 1.700 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.007276e-02 | 1.697 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.094924e-02 | 1.679 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.114451e-02 | 1.675 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.122574e-02 | 1.673 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.372352e-02 | 1.625 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.372352e-02 | 1.625 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.483025e-02 | 1.605 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.483025e-02 | 1.605 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.483025e-02 | 1.605 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.483025e-02 | 1.605 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.483025e-02 | 1.605 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.631095e-02 | 1.580 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.054769e-02 | 1.515 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.803956e-02 | 1.552 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.803956e-02 | 1.552 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.054769e-02 | 1.515 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.903754e-02 | 1.537 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.909615e-02 | 1.536 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.698794e-02 | 1.569 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.020005e-02 | 1.520 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.091180e-02 | 1.510 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.172931e-02 | 1.499 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.221060e-02 | 1.492 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.221060e-02 | 1.492 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.265729e-02 | 1.486 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.300355e-02 | 1.481 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.344133e-02 | 1.476 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.584331e-02 | 1.446 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.644967e-02 | 1.438 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.644967e-02 | 1.438 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.694808e-02 | 1.432 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.730167e-02 | 1.428 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.745713e-02 | 1.426 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.745713e-02 | 1.426 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.854643e-02 | 1.414 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.907330e-02 | 1.408 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.916944e-02 | 1.407 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.919281e-02 | 1.407 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.970368e-02 | 1.401 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.976522e-02 | 1.400 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.026186e-02 | 1.395 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.026186e-02 | 1.395 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.026186e-02 | 1.395 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.026186e-02 | 1.395 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.027716e-02 | 1.395 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.403339e-02 | 1.356 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.403339e-02 | 1.356 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.597825e-02 | 1.337 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.753421e-02 | 1.323 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.721152e-02 | 1.326 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.456239e-02 | 1.351 | 1 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.380229e-02 | 1.359 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.456239e-02 | 1.351 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.713851e-02 | 1.327 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.417996e-02 | 1.355 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.771124e-02 | 1.321 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.776520e-02 | 1.321 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.776520e-02 | 1.321 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.926218e-02 | 1.307 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.971776e-02 | 1.303 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.971776e-02 | 1.303 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.971776e-02 | 1.303 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.971776e-02 | 1.303 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.099539e-02 | 1.292 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.119885e-02 | 1.291 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.146407e-02 | 1.288 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.385377e-02 | 1.269 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.560607e-02 | 1.255 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.586755e-02 | 1.253 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.609741e-02 | 1.251 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.609741e-02 | 1.251 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.624773e-02 | 1.250 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.624773e-02 | 1.250 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.624773e-02 | 1.250 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.624773e-02 | 1.250 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.636927e-02 | 1.249 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.636927e-02 | 1.249 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.770772e-02 | 1.239 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.369437e-02 | 1.196 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.369437e-02 | 1.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.507649e-02 | 1.187 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.982923e-02 | 1.156 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.982923e-02 | 1.156 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.982923e-02 | 1.156 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.982923e-02 | 1.156 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.982923e-02 | 1.156 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.982923e-02 | 1.156 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.982923e-02 | 1.156 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.811764e-02 | 1.167 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.010874e-02 | 1.154 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.010874e-02 | 1.154 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.010874e-02 | 1.154 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.010874e-02 | 1.154 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.350726e-02 | 1.197 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.497269e-02 | 1.187 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.423824e-02 | 1.192 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.010874e-02 | 1.154 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.507649e-02 | 1.187 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.953465e-02 | 1.225 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.697663e-02 | 1.174 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.507649e-02 | 1.187 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.496558e-02 | 1.187 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.507649e-02 | 1.187 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.507649e-02 | 1.187 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.159497e-02 | 1.145 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.164707e-02 | 1.145 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.164707e-02 | 1.145 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.268270e-02 | 1.139 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.358853e-02 | 1.133 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.509665e-02 | 1.124 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.607989e-02 | 1.119 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.905418e-02 | 1.102 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.919354e-02 | 1.101 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.929327e-02 | 1.101 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.117756e-02 | 1.091 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.139430e-02 | 1.089 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.254376e-02 | 1.083 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.297478e-02 | 1.081 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.038100e-01 | 0.984 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.038100e-01 | 0.984 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.038100e-01 | 0.984 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.038100e-01 | 0.984 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.038100e-01 | 0.984 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.038100e-01 | 0.984 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.038100e-01 | 0.984 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.038100e-01 | 0.984 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.038100e-01 | 0.984 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.038100e-01 | 0.984 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.038100e-01 | 0.984 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.038100e-01 | 0.984 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 9.713301e-02 | 1.013 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 9.713301e-02 | 1.013 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 9.713301e-02 | 1.013 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 9.713301e-02 | 1.013 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 9.713301e-02 | 1.013 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.321233e-02 | 1.080 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.321233e-02 | 1.080 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.321233e-02 | 1.080 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.505361e-02 | 1.070 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.018704e-01 | 0.992 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.018704e-01 | 0.992 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.722142e-02 | 1.012 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.538925e-02 | 1.069 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.213666e-02 | 1.036 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.867930e-02 | 1.052 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.867930e-02 | 1.052 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.584839e-02 | 1.066 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.722142e-02 | 1.012 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.722142e-02 | 1.012 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.538925e-02 | 1.069 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.033285e-01 | 0.986 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.538925e-02 | 1.069 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.016221e-01 | 0.993 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.033619e-01 | 0.986 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.033619e-01 | 0.986 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.005763e-01 | 0.998 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.035430e-01 | 0.985 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.003824e-01 | 0.998 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.321233e-02 | 1.080 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.896717e-02 | 1.005 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.983687e-02 | 1.001 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.475821e-02 | 1.072 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.789155e-02 | 1.056 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.584839e-02 | 1.066 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.026293e-01 | 0.989 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.035430e-01 | 0.985 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.722142e-02 | 1.012 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.685217e-02 | 1.061 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.035430e-01 | 0.985 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.016221e-01 | 0.993 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.460947e-02 | 1.073 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.146193e-02 | 1.039 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.049735e-02 | 1.043 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.722142e-02 | 1.012 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.713301e-02 | 1.013 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.058731e-01 | 0.975 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.075534e-01 | 0.968 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.079466e-01 | 0.967 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.082068e-01 | 0.966 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.088411e-01 | 0.963 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.091694e-01 | 0.962 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.093036e-01 | 0.961 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.093036e-01 | 0.961 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.112820e-01 | 0.954 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.126789e-01 | 0.948 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.126789e-01 | 0.948 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.126789e-01 | 0.948 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.132266e-01 | 0.946 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.135828e-01 | 0.945 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.144442e-01 | 0.941 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.144442e-01 | 0.941 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.144442e-01 | 0.941 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.159465e-01 | 0.936 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.159465e-01 | 0.936 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.271606e-01 | 0.896 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.271606e-01 | 0.896 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.271606e-01 | 0.896 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.271606e-01 | 0.896 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.271606e-01 | 0.896 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.488655e-01 | 0.827 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.488655e-01 | 0.827 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.257099e-01 | 0.901 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.257099e-01 | 0.901 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.568723e-01 | 0.804 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.568723e-01 | 0.804 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.568723e-01 | 0.804 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.568723e-01 | 0.804 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.568723e-01 | 0.804 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.568723e-01 | 0.804 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.568723e-01 | 0.804 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.258996e-01 | 0.900 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.258996e-01 | 0.900 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.258996e-01 | 0.900 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.258996e-01 | 0.900 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.500819e-01 | 0.824 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.202050e-01 | 0.920 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.202050e-01 | 0.920 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.399617e-01 | 0.854 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.399617e-01 | 0.854 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.225002e-01 | 0.912 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.197282e-01 | 0.922 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.448449e-01 | 0.839 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.496016e-01 | 0.825 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.184515e-01 | 0.926 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.502666e-01 | 0.823 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.470205e-01 | 0.833 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.368016e-01 | 0.864 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.368016e-01 | 0.864 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.512545e-01 | 0.820 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.197282e-01 | 0.922 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.568723e-01 | 0.804 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.512545e-01 | 0.820 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.436143e-01 | 0.843 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.396074e-01 | 0.855 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.242143e-01 | 0.906 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.234113e-01 | 0.909 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.247093e-01 | 0.904 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.462081e-01 | 0.835 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.500819e-01 | 0.824 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.500819e-01 | 0.824 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.234113e-01 | 0.909 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.496016e-01 | 0.825 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.294259e-01 | 0.888 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.430821e-01 | 0.844 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.341717e-01 | 0.872 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.202050e-01 | 0.920 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.415252e-01 | 0.849 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.595073e-01 | 0.797 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.631083e-01 | 0.788 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.648016e-01 | 0.783 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.657716e-01 | 0.780 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.665124e-01 | 0.779 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.667470e-01 | 0.778 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.667470e-01 | 0.778 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.667470e-01 | 0.778 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.667470e-01 | 0.778 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.667470e-01 | 0.778 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.667470e-01 | 0.778 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.667470e-01 | 0.778 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.688368e-01 | 0.773 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.718185e-01 | 0.765 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.758677e-01 | 0.755 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.381579e-01 | 0.623 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.381579e-01 | 0.623 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.381579e-01 | 0.623 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.381579e-01 | 0.623 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.381579e-01 | 0.623 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.381579e-01 | 0.623 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.381579e-01 | 0.623 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.381579e-01 | 0.623 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.969570e-01 | 0.706 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.969570e-01 | 0.706 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.969570e-01 | 0.706 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.969570e-01 | 0.706 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.969570e-01 | 0.706 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.969570e-01 | 0.706 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.969570e-01 | 0.706 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.969570e-01 | 0.706 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.350454e-01 | 0.475 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.350454e-01 | 0.475 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.350454e-01 | 0.475 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.350454e-01 | 0.475 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.350454e-01 | 0.475 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.350454e-01 | 0.475 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.350454e-01 | 0.475 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.350454e-01 | 0.475 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.350454e-01 | 0.475 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.350454e-01 | 0.475 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.350454e-01 | 0.475 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.350454e-01 | 0.475 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.350454e-01 | 0.475 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.350454e-01 | 0.475 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.350454e-01 | 0.475 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.350454e-01 | 0.475 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.350454e-01 | 0.475 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.350454e-01 | 0.475 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.350454e-01 | 0.475 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.350454e-01 | 0.475 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.350454e-01 | 0.475 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.350454e-01 | 0.475 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.350454e-01 | 0.475 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.350454e-01 | 0.475 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.350454e-01 | 0.475 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.350454e-01 | 0.475 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.465847e-01 | 0.608 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.465847e-01 | 0.608 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.465847e-01 | 0.608 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.901052e-01 | 0.721 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.901052e-01 | 0.721 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 1.901052e-01 | 0.721 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.901052e-01 | 0.721 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.901052e-01 | 0.721 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.901052e-01 | 0.721 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.249060e-01 | 0.648 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.249060e-01 | 0.648 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.249060e-01 | 0.648 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.249060e-01 | 0.648 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.965811e-01 | 0.528 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.196162e-01 | 0.377 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.196162e-01 | 0.377 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.196162e-01 | 0.377 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.196162e-01 | 0.377 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.196162e-01 | 0.377 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.196162e-01 | 0.377 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.196162e-01 | 0.377 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.196162e-01 | 0.377 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.030212e-01 | 0.692 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.030212e-01 | 0.692 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.607992e-01 | 0.584 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.607992e-01 | 0.584 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.607992e-01 | 0.584 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.607992e-01 | 0.584 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.607992e-01 | 0.584 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.607992e-01 | 0.584 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.460502e-01 | 0.461 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.460502e-01 | 0.461 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.460502e-01 | 0.461 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.973465e-01 | 0.527 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.973465e-01 | 0.527 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.604662e-01 | 0.584 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.604662e-01 | 0.584 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.604662e-01 | 0.584 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.604662e-01 | 0.584 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.604662e-01 | 0.584 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.307726e-01 | 0.637 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.060306e-01 | 0.686 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.829310e-01 | 0.738 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.273556e-01 | 0.643 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.557294e-01 | 0.592 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.557294e-01 | 0.592 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.902813e-01 | 0.537 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.902813e-01 | 0.537 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.902813e-01 | 0.537 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.902813e-01 | 0.537 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.341520e-01 | 0.476 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.341520e-01 | 0.476 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.341520e-01 | 0.476 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.341520e-01 | 0.476 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.943179e-01 | 0.404 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.943179e-01 | 0.404 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.943179e-01 | 0.404 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.943179e-01 | 0.404 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.943179e-01 | 0.404 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.943179e-01 | 0.404 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.943179e-01 | 0.404 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.934352e-01 | 0.307 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.934352e-01 | 0.307 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.934352e-01 | 0.307 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.934352e-01 | 0.307 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.934352e-01 | 0.307 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.934352e-01 | 0.307 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.934352e-01 | 0.307 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.934352e-01 | 0.307 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.934352e-01 | 0.307 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.934352e-01 | 0.307 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.800090e-01 | 0.745 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.997613e-01 | 0.699 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.225936e-01 | 0.652 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.493477e-01 | 0.603 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.205208e-01 | 0.494 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.205208e-01 | 0.494 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.205208e-01 | 0.494 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.205208e-01 | 0.494 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.423438e-01 | 0.616 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.708654e-01 | 0.431 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.708654e-01 | 0.431 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.708654e-01 | 0.431 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.708654e-01 | 0.431 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.708654e-01 | 0.431 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.626202e-01 | 0.581 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.999496e-01 | 0.699 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.509721e-01 | 0.455 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.408899e-01 | 0.356 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.408899e-01 | 0.356 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.408899e-01 | 0.356 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.408899e-01 | 0.356 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.408899e-01 | 0.356 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.408899e-01 | 0.356 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.141937e-01 | 0.669 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.833481e-01 | 0.548 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.071823e-01 | 0.390 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.814378e-01 | 0.419 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.602112e-01 | 0.443 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.926701e-01 | 0.715 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.419612e-01 | 0.466 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.113871e-01 | 0.507 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.030718e-01 | 0.692 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.861311e-01 | 0.543 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.861311e-01 | 0.543 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.000717e-01 | 0.699 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.100278e-01 | 0.678 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.657738e-01 | 0.437 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.867999e-01 | 0.413 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.867999e-01 | 0.413 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.117374e-01 | 0.385 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.117374e-01 | 0.385 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.117374e-01 | 0.385 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.428430e-01 | 0.354 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.428430e-01 | 0.354 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.428430e-01 | 0.354 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.854170e-01 | 0.314 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.854170e-01 | 0.314 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.854170e-01 | 0.314 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.071457e-01 | 0.513 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.071457e-01 | 0.513 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.205392e-01 | 0.494 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.512794e-01 | 0.454 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.235933e-01 | 0.490 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.133199e-01 | 0.384 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.133199e-01 | 0.384 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.714643e-01 | 0.430 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.417081e-01 | 0.355 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.417081e-01 | 0.355 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.417081e-01 | 0.355 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.417081e-01 | 0.355 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.417081e-01 | 0.355 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.946913e-01 | 0.531 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.776308e-01 | 0.321 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.776308e-01 | 0.321 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.776308e-01 | 0.321 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.776308e-01 | 0.321 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.396578e-01 | 0.357 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.712054e-01 | 0.327 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.276660e-01 | 0.278 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.276660e-01 | 0.278 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.347983e-01 | 0.362 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.657092e-01 | 0.332 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.657092e-01 | 0.332 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.608610e-01 | 0.336 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.608610e-01 | 0.336 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.113686e-01 | 0.291 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.564893e-01 | 0.341 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.503287e-01 | 0.456 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.001027e-01 | 0.301 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.913797e-01 | 0.309 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.913797e-01 | 0.309 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.841823e-01 | 0.315 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.841823e-01 | 0.315 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.841823e-01 | 0.315 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.676372e-01 | 0.330 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.992785e-01 | 0.302 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.992785e-01 | 0.302 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.992785e-01 | 0.302 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.165844e-01 | 0.287 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.165844e-01 | 0.287 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.049436e-01 | 0.297 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.180467e-01 | 0.379 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.590136e-01 | 0.338 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.557383e-01 | 0.341 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.307726e-01 | 0.637 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.065729e-01 | 0.685 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.604662e-01 | 0.584 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.100278e-01 | 0.678 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.866442e-01 | 0.729 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.183136e-01 | 0.497 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.932265e-01 | 0.714 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.249060e-01 | 0.648 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.341520e-01 | 0.476 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.205208e-01 | 0.494 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.322942e-01 | 0.364 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.165844e-01 | 0.287 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.065729e-01 | 0.685 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.408899e-01 | 0.356 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.072385e-01 | 0.684 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.833090e-01 | 0.548 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.833090e-01 | 0.548 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.235933e-01 | 0.490 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.739300e-01 | 0.427 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.739094e-01 | 0.427 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.739094e-01 | 0.427 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.113871e-01 | 0.507 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.592470e-01 | 0.586 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.465847e-01 | 0.608 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.474833e-01 | 0.459 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.776308e-01 | 0.321 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.208135e-01 | 0.494 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.030212e-01 | 0.692 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.249060e-01 | 0.648 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.607992e-01 | 0.584 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.071823e-01 | 0.390 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.258552e-01 | 0.487 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.271079e-01 | 0.644 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.120264e-01 | 0.385 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.965811e-01 | 0.528 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 2.030212e-01 | 0.692 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.607992e-01 | 0.584 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.607992e-01 | 0.584 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 2.973465e-01 | 0.527 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.408899e-01 | 0.356 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.854170e-01 | 0.314 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.129876e-01 | 0.384 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.113686e-01 | 0.291 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.420192e-01 | 0.355 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.859648e-01 | 0.413 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.884678e-01 | 0.540 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.608610e-01 | 0.336 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.954832e-01 | 0.709 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.949285e-01 | 0.530 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.434892e-01 | 0.614 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.969570e-01 | 0.706 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.465847e-01 | 0.608 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.249060e-01 | 0.648 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.341520e-01 | 0.476 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.708654e-01 | 0.431 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.776308e-01 | 0.321 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.372830e-01 | 0.359 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.113686e-01 | 0.291 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.434892e-01 | 0.614 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.396578e-01 | 0.357 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.058383e-01 | 0.515 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.607992e-01 | 0.584 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.829310e-01 | 0.738 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.708654e-01 | 0.431 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.512794e-01 | 0.454 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.435091e-01 | 0.353 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.902813e-01 | 0.537 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.756907e-01 | 0.560 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.043394e-01 | 0.690 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.202111e-01 | 0.657 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.185974e-01 | 0.378 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.999848e-01 | 0.699 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 1.901052e-01 | 0.721 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.249060e-01 | 0.648 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.313010e-01 | 0.636 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.460502e-01 | 0.461 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.943179e-01 | 0.404 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.044517e-01 | 0.516 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.133199e-01 | 0.384 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.756907e-01 | 0.560 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.917319e-01 | 0.407 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.093298e-01 | 0.510 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.322942e-01 | 0.364 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.614560e-01 | 0.336 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.202702e-01 | 0.284 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.355374e-01 | 0.361 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.443464e-01 | 0.463 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.682724e-01 | 0.571 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.492769e-01 | 0.347 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.714643e-01 | 0.430 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.259700e-01 | 0.279 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.093298e-01 | 0.510 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.859648e-01 | 0.413 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.657738e-01 | 0.437 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.728149e-01 | 0.429 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.728149e-01 | 0.429 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.100278e-01 | 0.678 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.313010e-01 | 0.636 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.854712e-01 | 0.732 | 1 | 1 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.034425e-01 | 0.692 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.913797e-01 | 0.309 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.847509e-01 | 0.314 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.155585e-01 | 0.288 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.630377e-01 | 0.580 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.182338e-01 | 0.497 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.171891e-01 | 0.663 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.970760e-01 | 0.527 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.969570e-01 | 0.706 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.965811e-01 | 0.528 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.604662e-01 | 0.584 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.030718e-01 | 0.692 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.372830e-01 | 0.359 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.836581e-01 | 0.416 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.225936e-01 | 0.652 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.460502e-01 | 0.461 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.780011e-01 | 0.321 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.548402e-01 | 0.342 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.071791e-01 | 0.295 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.692622e-01 | 0.433 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.113871e-01 | 0.507 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.813383e-01 | 0.742 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.042607e-01 | 0.690 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.381579e-01 | 0.623 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.901052e-01 | 0.721 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.249060e-01 | 0.648 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.965811e-01 | 0.528 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.965811e-01 | 0.528 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.196162e-01 | 0.377 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.065729e-01 | 0.685 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.973465e-01 | 0.527 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.902813e-01 | 0.537 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.934352e-01 | 0.307 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.493477e-01 | 0.603 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.708654e-01 | 0.431 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.408899e-01 | 0.356 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.353865e-01 | 0.628 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.428430e-01 | 0.354 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.428430e-01 | 0.354 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.345045e-01 | 0.630 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.396578e-01 | 0.357 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.712054e-01 | 0.327 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.347983e-01 | 0.362 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.657092e-01 | 0.332 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.113686e-01 | 0.291 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.448656e-01 | 0.352 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.225966e-01 | 0.282 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.186951e-01 | 0.497 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.143561e-01 | 0.289 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.849608e-01 | 0.733 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.482094e-01 | 0.458 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.739300e-01 | 0.427 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.833481e-01 | 0.548 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.608610e-01 | 0.336 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.402257e-01 | 0.468 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.886980e-01 | 0.724 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.973465e-01 | 0.527 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.073255e-01 | 0.512 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.336763e-01 | 0.477 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.258552e-01 | 0.487 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.854170e-01 | 0.314 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.276660e-01 | 0.278 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.075408e-01 | 0.390 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.165844e-01 | 0.287 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.278008e-01 | 0.484 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.902813e-01 | 0.537 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.372830e-01 | 0.359 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.276660e-01 | 0.278 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.512794e-01 | 0.454 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.656414e-01 | 0.437 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.045573e-01 | 0.297 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.249060e-01 | 0.648 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.965811e-01 | 0.528 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.460502e-01 | 0.461 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.943179e-01 | 0.404 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.408899e-01 | 0.356 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.071823e-01 | 0.390 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.417081e-01 | 0.355 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.839510e-01 | 0.735 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.120264e-01 | 0.385 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.841823e-01 | 0.315 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.833090e-01 | 0.548 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.133199e-01 | 0.384 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.551550e-01 | 0.342 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.602112e-01 | 0.443 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.196162e-01 | 0.377 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.607992e-01 | 0.584 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.934352e-01 | 0.307 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.934352e-01 | 0.307 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.509721e-01 | 0.455 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.258552e-01 | 0.487 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.854170e-01 | 0.314 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.776308e-01 | 0.321 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.276660e-01 | 0.278 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.001027e-01 | 0.301 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.676372e-01 | 0.330 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.165844e-01 | 0.287 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.874459e-01 | 0.312 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.495690e-01 | 0.456 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.419019e-01 | 0.355 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.000717e-01 | 0.699 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.165796e-01 | 0.500 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.871123e-01 | 0.412 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.000717e-01 | 0.699 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.934352e-01 | 0.307 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.225936e-01 | 0.652 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.705494e-01 | 0.568 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.010936e-01 | 0.697 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.602112e-01 | 0.443 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.776308e-01 | 0.321 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.937055e-01 | 0.713 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.965811e-01 | 0.528 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.196162e-01 | 0.377 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.196162e-01 | 0.377 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.943179e-01 | 0.404 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.943179e-01 | 0.404 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.934352e-01 | 0.307 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.934352e-01 | 0.307 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.408899e-01 | 0.356 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.070130e-01 | 0.513 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.276660e-01 | 0.278 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.324258e-01 | 0.478 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.047712e-01 | 0.393 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.001027e-01 | 0.301 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.713730e-01 | 0.430 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.902813e-01 | 0.537 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.915350e-01 | 0.535 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.435037e-01 | 0.353 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.943179e-01 | 0.404 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.934352e-01 | 0.307 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.854170e-01 | 0.314 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.854170e-01 | 0.314 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.012254e-01 | 0.696 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.739094e-01 | 0.427 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.814378e-01 | 0.419 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.712054e-01 | 0.327 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.066992e-01 | 0.685 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.071823e-01 | 0.390 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.582935e-01 | 0.446 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.428430e-01 | 0.354 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.276660e-01 | 0.278 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.282912e-01 | 0.277 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.297902e-01 | 0.276 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.344253e-01 | 0.272 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.409292e-01 | 0.267 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.412487e-01 | 0.267 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.412487e-01 | 0.267 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.412487e-01 | 0.267 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.412487e-01 | 0.267 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.412487e-01 | 0.267 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.414416e-01 | 0.266 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.433789e-01 | 0.265 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.439159e-01 | 0.264 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.439159e-01 | 0.264 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.439159e-01 | 0.264 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.439159e-01 | 0.264 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.439159e-01 | 0.264 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.439159e-01 | 0.264 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.439159e-01 | 0.264 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.439159e-01 | 0.264 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.439159e-01 | 0.264 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.439159e-01 | 0.264 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.444852e-01 | 0.264 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.481541e-01 | 0.261 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.519603e-01 | 0.258 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.519603e-01 | 0.258 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.556792e-01 | 0.255 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.574148e-01 | 0.254 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 5.578690e-01 | 0.253 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.578690e-01 | 0.253 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.578690e-01 | 0.253 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.578690e-01 | 0.253 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.578690e-01 | 0.253 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.578690e-01 | 0.253 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 5.578690e-01 | 0.253 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.578690e-01 | 0.253 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.578690e-01 | 0.253 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.578690e-01 | 0.253 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.578690e-01 | 0.253 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.578690e-01 | 0.253 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.578690e-01 | 0.253 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.578690e-01 | 0.253 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.583432e-01 | 0.253 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.593068e-01 | 0.252 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.651932e-01 | 0.248 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.653073e-01 | 0.248 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.653073e-01 | 0.248 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.653073e-01 | 0.248 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.674822e-01 | 0.246 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.674962e-01 | 0.246 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.674962e-01 | 0.246 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.674962e-01 | 0.246 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.674962e-01 | 0.246 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.674962e-01 | 0.246 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.674962e-01 | 0.246 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.694328e-01 | 0.245 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.694328e-01 | 0.245 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.736404e-01 | 0.241 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.736404e-01 | 0.241 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.751651e-01 | 0.240 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.751651e-01 | 0.240 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.751651e-01 | 0.240 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.751651e-01 | 0.240 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.751651e-01 | 0.240 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.751651e-01 | 0.240 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.751651e-01 | 0.240 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.768780e-01 | 0.239 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.768780e-01 | 0.239 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.768780e-01 | 0.239 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.768780e-01 | 0.239 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.768780e-01 | 0.239 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.807345e-01 | 0.236 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.810828e-01 | 0.236 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.810828e-01 | 0.236 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.821908e-01 | 0.235 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.821908e-01 | 0.235 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.821908e-01 | 0.235 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.821908e-01 | 0.235 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.873541e-01 | 0.231 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.878641e-01 | 0.231 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.878641e-01 | 0.231 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.899003e-01 | 0.229 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.900654e-01 | 0.229 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.941295e-01 | 0.226 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.947878e-01 | 0.226 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.005049e-01 | 0.221 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.005049e-01 | 0.221 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.005049e-01 | 0.221 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.005049e-01 | 0.221 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 6.048393e-01 | 0.218 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.048393e-01 | 0.218 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.048393e-01 | 0.218 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.048393e-01 | 0.218 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.048393e-01 | 0.218 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.048393e-01 | 0.218 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.048393e-01 | 0.218 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.050379e-01 | 0.218 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.050379e-01 | 0.218 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.050379e-01 | 0.218 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.077656e-01 | 0.216 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.077656e-01 | 0.216 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.077656e-01 | 0.216 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.077656e-01 | 0.216 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.106833e-01 | 0.214 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.113939e-01 | 0.214 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.113939e-01 | 0.214 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.141102e-01 | 0.212 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.141102e-01 | 0.212 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.141102e-01 | 0.212 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.141102e-01 | 0.212 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.141102e-01 | 0.212 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.141102e-01 | 0.212 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.141102e-01 | 0.212 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.141102e-01 | 0.212 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.141102e-01 | 0.212 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.141102e-01 | 0.212 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.141102e-01 | 0.212 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.141102e-01 | 0.212 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.141102e-01 | 0.212 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 6.141102e-01 | 0.212 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.153655e-01 | 0.211 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.153655e-01 | 0.211 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.153655e-01 | 0.211 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.153655e-01 | 0.211 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.153655e-01 | 0.211 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.165881e-01 | 0.210 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.181196e-01 | 0.209 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.186687e-01 | 0.209 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.194493e-01 | 0.208 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.235392e-01 | 0.205 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.323570e-01 | 0.199 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.323570e-01 | 0.199 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.323570e-01 | 0.199 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.333372e-01 | 0.198 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.334820e-01 | 0.198 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.334820e-01 | 0.198 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.334820e-01 | 0.198 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.353425e-01 | 0.197 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.378905e-01 | 0.195 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.378905e-01 | 0.195 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.378905e-01 | 0.195 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.396835e-01 | 0.194 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.396835e-01 | 0.194 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.396835e-01 | 0.194 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.396835e-01 | 0.194 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.396835e-01 | 0.194 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.396835e-01 | 0.194 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.396835e-01 | 0.194 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.396835e-01 | 0.194 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.396835e-01 | 0.194 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.396835e-01 | 0.194 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.396835e-01 | 0.194 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.396835e-01 | 0.194 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.396835e-01 | 0.194 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.396835e-01 | 0.194 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.429572e-01 | 0.192 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.437463e-01 | 0.191 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.545043e-01 | 0.184 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.546932e-01 | 0.184 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.546932e-01 | 0.184 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.546932e-01 | 0.184 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.558066e-01 | 0.183 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.558066e-01 | 0.183 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.559312e-01 | 0.183 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.559312e-01 | 0.183 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.559312e-01 | 0.183 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.559312e-01 | 0.183 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.559312e-01 | 0.183 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.574818e-01 | 0.182 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.586460e-01 | 0.181 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.595114e-01 | 0.181 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.604675e-01 | 0.180 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.604675e-01 | 0.180 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.604675e-01 | 0.180 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.604675e-01 | 0.180 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.617691e-01 | 0.179 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.617691e-01 | 0.179 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.632001e-01 | 0.178 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.632001e-01 | 0.178 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.632001e-01 | 0.178 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.632001e-01 | 0.178 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.632001e-01 | 0.178 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.632001e-01 | 0.178 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.632001e-01 | 0.178 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.632001e-01 | 0.178 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.632001e-01 | 0.178 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.632001e-01 | 0.178 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.632001e-01 | 0.178 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.632001e-01 | 0.178 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.632001e-01 | 0.178 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 6.632001e-01 | 0.178 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.632001e-01 | 0.178 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.632001e-01 | 0.178 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.632001e-01 | 0.178 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.632001e-01 | 0.178 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.632001e-01 | 0.178 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.632001e-01 | 0.178 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.632001e-01 | 0.178 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.632001e-01 | 0.178 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.632001e-01 | 0.178 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.632001e-01 | 0.178 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.632001e-01 | 0.178 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.632001e-01 | 0.178 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.641746e-01 | 0.178 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.720603e-01 | 0.173 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.720603e-01 | 0.173 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.720603e-01 | 0.173 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.720603e-01 | 0.173 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.720603e-01 | 0.173 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.720603e-01 | 0.173 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.720603e-01 | 0.173 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 6.720603e-01 | 0.173 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.720603e-01 | 0.173 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.720603e-01 | 0.173 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.720603e-01 | 0.173 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.731797e-01 | 0.172 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.737588e-01 | 0.171 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.748728e-01 | 0.171 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.763301e-01 | 0.170 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.770817e-01 | 0.169 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.784658e-01 | 0.168 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.784658e-01 | 0.168 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.784658e-01 | 0.168 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.826455e-01 | 0.166 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.859836e-01 | 0.164 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.859836e-01 | 0.164 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.859836e-01 | 0.164 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.859836e-01 | 0.164 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.895548e-01 | 0.161 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.932571e-01 | 0.159 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.944273e-01 | 0.158 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.944273e-01 | 0.158 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.972910e-01 | 0.157 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.999491e-01 | 0.155 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.999491e-01 | 0.155 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.020335e-01 | 0.154 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.020335e-01 | 0.154 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.020335e-01 | 0.154 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.053581e-01 | 0.152 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.060477e-01 | 0.151 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.060477e-01 | 0.151 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.060477e-01 | 0.151 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.060477e-01 | 0.151 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.060477e-01 | 0.151 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.060477e-01 | 0.151 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.060477e-01 | 0.151 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.060477e-01 | 0.151 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.062437e-01 | 0.151 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.088085e-01 | 0.149 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.100360e-01 | 0.149 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.100360e-01 | 0.149 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.100360e-01 | 0.149 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.131585e-01 | 0.147 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.131585e-01 | 0.147 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.131585e-01 | 0.147 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.136707e-01 | 0.147 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.187799e-01 | 0.143 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.203782e-01 | 0.142 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.203782e-01 | 0.142 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.254983e-01 | 0.139 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.254983e-01 | 0.139 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.254983e-01 | 0.139 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.254983e-01 | 0.139 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.296906e-01 | 0.137 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.296906e-01 | 0.137 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.296906e-01 | 0.137 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.296906e-01 | 0.137 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.296906e-01 | 0.137 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.310630e-01 | 0.136 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.326439e-01 | 0.135 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.326439e-01 | 0.135 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.326439e-01 | 0.135 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.326439e-01 | 0.135 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.326439e-01 | 0.135 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.326439e-01 | 0.135 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.339684e-01 | 0.134 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.367104e-01 | 0.133 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.367300e-01 | 0.133 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.378474e-01 | 0.132 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.384354e-01 | 0.132 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.397586e-01 | 0.131 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.397586e-01 | 0.131 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.415061e-01 | 0.130 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.415061e-01 | 0.130 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.418146e-01 | 0.130 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.434464e-01 | 0.129 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.434464e-01 | 0.129 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.434464e-01 | 0.129 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.434464e-01 | 0.129 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.434464e-01 | 0.129 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.434464e-01 | 0.129 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.434464e-01 | 0.129 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.434464e-01 | 0.129 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.434464e-01 | 0.129 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.434464e-01 | 0.129 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.434464e-01 | 0.129 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.449795e-01 | 0.128 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.451262e-01 | 0.128 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.460115e-01 | 0.127 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.481427e-01 | 0.126 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.515196e-01 | 0.124 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.551356e-01 | 0.122 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.551356e-01 | 0.122 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.551356e-01 | 0.122 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.551356e-01 | 0.122 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.551356e-01 | 0.122 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.551356e-01 | 0.122 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.568328e-01 | 0.121 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.573005e-01 | 0.121 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.578391e-01 | 0.120 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.581026e-01 | 0.120 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.581026e-01 | 0.120 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.610514e-01 | 0.119 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.644039e-01 | 0.117 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.644039e-01 | 0.117 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.644039e-01 | 0.117 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.644039e-01 | 0.117 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.644039e-01 | 0.117 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.644039e-01 | 0.117 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.644039e-01 | 0.117 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.654496e-01 | 0.116 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.654496e-01 | 0.116 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.654496e-01 | 0.116 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.736566e-01 | 0.111 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.736566e-01 | 0.111 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.736566e-01 | 0.111 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.743445e-01 | 0.111 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.754283e-01 | 0.110 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.760888e-01 | 0.110 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.760888e-01 | 0.110 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.760888e-01 | 0.110 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.760888e-01 | 0.110 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.760888e-01 | 0.110 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.760888e-01 | 0.110 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.760888e-01 | 0.110 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.760888e-01 | 0.110 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.760888e-01 | 0.110 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.760888e-01 | 0.110 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.784837e-01 | 0.109 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.784837e-01 | 0.109 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.784837e-01 | 0.109 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.784837e-01 | 0.109 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.788020e-01 | 0.109 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.798571e-01 | 0.108 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.798571e-01 | 0.108 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.798571e-01 | 0.108 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.819136e-01 | 0.107 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.893497e-01 | 0.103 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.896696e-01 | 0.103 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.896696e-01 | 0.103 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.917592e-01 | 0.101 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.917592e-01 | 0.101 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.917592e-01 | 0.101 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.917592e-01 | 0.101 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.921473e-01 | 0.101 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.921473e-01 | 0.101 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.932791e-01 | 0.101 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.945163e-01 | 0.100 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.945163e-01 | 0.100 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.945163e-01 | 0.100 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.945163e-01 | 0.100 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.987124e-01 | 0.098 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.998564e-01 | 0.097 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.998564e-01 | 0.097 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.998564e-01 | 0.097 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.037976e-01 | 0.095 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.037976e-01 | 0.095 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.041183e-01 | 0.095 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.045797e-01 | 0.094 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.045797e-01 | 0.094 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.045797e-01 | 0.094 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.045797e-01 | 0.094 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.045797e-01 | 0.094 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.045797e-01 | 0.094 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.045797e-01 | 0.094 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.045797e-01 | 0.094 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 8.045797e-01 | 0.094 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.045797e-01 | 0.094 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 8.045797e-01 | 0.094 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 8.045797e-01 | 0.094 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.071225e-01 | 0.093 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.071225e-01 | 0.093 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.071225e-01 | 0.093 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.071225e-01 | 0.093 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.091711e-01 | 0.092 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.093614e-01 | 0.092 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.093614e-01 | 0.092 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.093614e-01 | 0.092 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.093614e-01 | 0.092 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.105408e-01 | 0.091 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.110020e-01 | 0.091 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.154571e-01 | 0.089 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.185571e-01 | 0.087 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.193784e-01 | 0.087 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.193784e-01 | 0.087 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.193784e-01 | 0.087 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.193784e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.194901e-01 | 0.086 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.197424e-01 | 0.086 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.215234e-01 | 0.085 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.234904e-01 | 0.084 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.253547e-01 | 0.083 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.253547e-01 | 0.083 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.253547e-01 | 0.083 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.281375e-01 | 0.082 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.294467e-01 | 0.081 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.294467e-01 | 0.081 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.294467e-01 | 0.081 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.294467e-01 | 0.081 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.294467e-01 | 0.081 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.294467e-01 | 0.081 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.294467e-01 | 0.081 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.294467e-01 | 0.081 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.294467e-01 | 0.081 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.294467e-01 | 0.081 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.294467e-01 | 0.081 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.294467e-01 | 0.081 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.296199e-01 | 0.081 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.339128e-01 | 0.079 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.349083e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.350723e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.350723e-01 | 0.078 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.350723e-01 | 0.078 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.350723e-01 | 0.078 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.354010e-01 | 0.078 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.371745e-01 | 0.077 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.371745e-01 | 0.077 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.371745e-01 | 0.077 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.371745e-01 | 0.077 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.371745e-01 | 0.077 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.371745e-01 | 0.077 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.371745e-01 | 0.077 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.390844e-01 | 0.076 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.393757e-01 | 0.076 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.401422e-01 | 0.076 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.401854e-01 | 0.076 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.401854e-01 | 0.076 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.401854e-01 | 0.076 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.401854e-01 | 0.076 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.401854e-01 | 0.076 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.401854e-01 | 0.076 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.435808e-01 | 0.074 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.435808e-01 | 0.074 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.454877e-01 | 0.073 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.454877e-01 | 0.073 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.472126e-01 | 0.072 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.477277e-01 | 0.072 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.511507e-01 | 0.070 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.511507e-01 | 0.070 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.511507e-01 | 0.070 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.511507e-01 | 0.070 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.511507e-01 | 0.070 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.511507e-01 | 0.070 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.511507e-01 | 0.070 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.511507e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.511507e-01 | 0.070 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.511507e-01 | 0.070 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.511507e-01 | 0.070 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.511507e-01 | 0.070 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.533677e-01 | 0.069 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.533677e-01 | 0.069 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.539136e-01 | 0.069 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.539136e-01 | 0.069 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.539136e-01 | 0.069 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.559562e-01 | 0.068 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.589332e-01 | 0.066 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.665996e-01 | 0.062 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.665996e-01 | 0.062 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.669088e-01 | 0.062 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.680777e-01 | 0.061 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.680777e-01 | 0.061 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.680777e-01 | 0.061 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.680777e-01 | 0.061 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.680777e-01 | 0.061 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.694912e-01 | 0.061 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.700939e-01 | 0.060 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.700939e-01 | 0.060 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.700939e-01 | 0.060 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.700939e-01 | 0.060 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.700939e-01 | 0.060 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.700939e-01 | 0.060 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.700939e-01 | 0.060 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.700939e-01 | 0.060 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.705829e-01 | 0.060 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.705829e-01 | 0.060 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.723452e-01 | 0.059 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.764491e-01 | 0.057 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.783038e-01 | 0.056 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.783038e-01 | 0.056 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.783038e-01 | 0.056 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.783038e-01 | 0.056 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.783038e-01 | 0.056 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.799431e-01 | 0.056 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.808587e-01 | 0.055 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.814197e-01 | 0.055 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.814197e-01 | 0.055 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.814197e-01 | 0.055 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.814197e-01 | 0.055 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.833428e-01 | 0.054 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.833428e-01 | 0.054 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.856894e-01 | 0.053 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.866272e-01 | 0.052 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.866272e-01 | 0.052 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.866272e-01 | 0.052 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.866272e-01 | 0.052 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.866272e-01 | 0.052 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.866272e-01 | 0.052 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.866272e-01 | 0.052 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.866272e-01 | 0.052 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.866272e-01 | 0.052 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.879957e-01 | 0.052 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.904177e-01 | 0.050 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.933688e-01 | 0.049 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.935036e-01 | 0.049 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.935036e-01 | 0.049 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.935036e-01 | 0.049 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.935036e-01 | 0.049 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.935036e-01 | 0.049 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.941957e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.941957e-01 | 0.049 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.969684e-01 | 0.047 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.985114e-01 | 0.046 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.990047e-01 | 0.046 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.990047e-01 | 0.046 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.010571e-01 | 0.045 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.010571e-01 | 0.045 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.010571e-01 | 0.045 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.010571e-01 | 0.045 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.010571e-01 | 0.045 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.010571e-01 | 0.045 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.010571e-01 | 0.045 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.010571e-01 | 0.045 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.010571e-01 | 0.045 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.010571e-01 | 0.045 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.010571e-01 | 0.045 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.034487e-01 | 0.044 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.043206e-01 | 0.044 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.044333e-01 | 0.044 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.044333e-01 | 0.044 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.044333e-01 | 0.044 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.044333e-01 | 0.044 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.044333e-01 | 0.044 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.061942e-01 | 0.043 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.061942e-01 | 0.043 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.075374e-01 | 0.042 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.075374e-01 | 0.042 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.075374e-01 | 0.042 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.077267e-01 | 0.042 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.081164e-01 | 0.042 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.095768e-01 | 0.041 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.112202e-01 | 0.040 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.129007e-01 | 0.040 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.129007e-01 | 0.040 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.136512e-01 | 0.039 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.136512e-01 | 0.039 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.136512e-01 | 0.039 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.136512e-01 | 0.039 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.136512e-01 | 0.039 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.136512e-01 | 0.039 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.136512e-01 | 0.039 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.136512e-01 | 0.039 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.136512e-01 | 0.039 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.136512e-01 | 0.039 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.136512e-01 | 0.039 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.136512e-01 | 0.039 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.136512e-01 | 0.039 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.136512e-01 | 0.039 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.136512e-01 | 0.039 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.143070e-01 | 0.039 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.143070e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.151724e-01 | 0.038 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.154084e-01 | 0.038 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.164762e-01 | 0.038 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.164762e-01 | 0.038 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.164762e-01 | 0.038 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.164762e-01 | 0.038 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.165057e-01 | 0.038 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.202822e-01 | 0.036 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.222392e-01 | 0.035 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.229621e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.232162e-01 | 0.035 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.232162e-01 | 0.035 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.232162e-01 | 0.035 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.232162e-01 | 0.035 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.232162e-01 | 0.035 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.232162e-01 | 0.035 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.241366e-01 | 0.034 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.241366e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.246428e-01 | 0.034 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.246428e-01 | 0.034 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.246428e-01 | 0.034 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.246428e-01 | 0.034 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.246428e-01 | 0.034 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.246428e-01 | 0.034 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.246428e-01 | 0.034 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.246428e-01 | 0.034 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.246428e-01 | 0.034 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.246428e-01 | 0.034 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.246428e-01 | 0.034 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.246428e-01 | 0.034 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.246428e-01 | 0.034 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.246428e-01 | 0.034 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.246428e-01 | 0.034 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.250720e-01 | 0.034 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.287725e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.287725e-01 | 0.032 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.296040e-01 | 0.032 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.305773e-01 | 0.031 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.311479e-01 | 0.031 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.311479e-01 | 0.031 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.311479e-01 | 0.031 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.312466e-01 | 0.031 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.312466e-01 | 0.031 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.312466e-01 | 0.031 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.326549e-01 | 0.030 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.329607e-01 | 0.030 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.342359e-01 | 0.030 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.342359e-01 | 0.030 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.342359e-01 | 0.030 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.342359e-01 | 0.030 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.342359e-01 | 0.030 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.342359e-01 | 0.030 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.342359e-01 | 0.030 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.345371e-01 | 0.029 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.345371e-01 | 0.029 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.348061e-01 | 0.029 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.348061e-01 | 0.029 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.348061e-01 | 0.029 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.375580e-01 | 0.028 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.384773e-01 | 0.028 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.384773e-01 | 0.028 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.384773e-01 | 0.028 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.403721e-01 | 0.027 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.405253e-01 | 0.027 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.426082e-01 | 0.026 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.426082e-01 | 0.026 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.426082e-01 | 0.026 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.426082e-01 | 0.026 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.426082e-01 | 0.026 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.426082e-01 | 0.026 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.434122e-01 | 0.025 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.441870e-01 | 0.025 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.449819e-01 | 0.025 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.455017e-01 | 0.024 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.489878e-01 | 0.023 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.490353e-01 | 0.023 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.499151e-01 | 0.022 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.499151e-01 | 0.022 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.499151e-01 | 0.022 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.499151e-01 | 0.022 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.499151e-01 | 0.022 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.499151e-01 | 0.022 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.499151e-01 | 0.022 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.499151e-01 | 0.022 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.502245e-01 | 0.022 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.508280e-01 | 0.022 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.508280e-01 | 0.022 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.536213e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.537767e-01 | 0.021 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.560777e-01 | 0.020 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.562920e-01 | 0.019 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.562920e-01 | 0.019 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.562920e-01 | 0.019 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.562920e-01 | 0.019 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.562920e-01 | 0.019 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.562920e-01 | 0.019 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.562920e-01 | 0.019 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.562920e-01 | 0.019 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.562920e-01 | 0.019 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.562920e-01 | 0.019 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.570019e-01 | 0.019 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.579409e-01 | 0.019 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.580542e-01 | 0.019 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.585604e-01 | 0.018 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.605427e-01 | 0.017 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.605427e-01 | 0.017 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.605427e-01 | 0.017 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.607882e-01 | 0.017 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.607882e-01 | 0.017 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.611240e-01 | 0.017 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.618574e-01 | 0.017 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.618574e-01 | 0.017 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.620872e-01 | 0.017 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.620872e-01 | 0.017 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.638916e-01 | 0.016 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.655880e-01 | 0.015 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.667144e-01 | 0.015 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.667144e-01 | 0.015 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.667144e-01 | 0.015 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.667144e-01 | 0.015 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.667144e-01 | 0.015 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.673401e-01 | 0.014 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.686420e-01 | 0.014 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.709531e-01 | 0.013 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.709531e-01 | 0.013 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.709531e-01 | 0.013 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.709531e-01 | 0.013 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.709531e-01 | 0.013 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.709531e-01 | 0.013 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.709531e-01 | 0.013 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.709531e-01 | 0.013 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.709787e-01 | 0.013 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.710072e-01 | 0.013 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.711496e-01 | 0.013 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.711683e-01 | 0.013 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.711683e-01 | 0.013 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.712514e-01 | 0.013 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.714926e-01 | 0.013 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.720370e-01 | 0.012 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.721048e-01 | 0.012 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.721834e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.721834e-01 | 0.012 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.721834e-01 | 0.012 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.721877e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.735588e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.740757e-01 | 0.011 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.740757e-01 | 0.011 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.746523e-01 | 0.011 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.746523e-01 | 0.011 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.746523e-01 | 0.011 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.746523e-01 | 0.011 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.752147e-01 | 0.011 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.776687e-01 | 0.010 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.778806e-01 | 0.010 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.778806e-01 | 0.010 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.778806e-01 | 0.010 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.778806e-01 | 0.010 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.778806e-01 | 0.010 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.779253e-01 | 0.010 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.779253e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.779253e-01 | 0.010 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.794936e-01 | 0.009 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.797071e-01 | 0.009 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.797071e-01 | 0.009 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.797071e-01 | 0.009 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.806979e-01 | 0.008 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.806979e-01 | 0.008 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.806979e-01 | 0.008 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.806979e-01 | 0.008 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.807146e-01 | 0.008 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.816448e-01 | 0.008 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.823665e-01 | 0.008 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.823665e-01 | 0.008 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.825114e-01 | 0.008 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.825114e-01 | 0.008 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.825114e-01 | 0.008 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.825114e-01 | 0.008 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.831565e-01 | 0.007 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.831565e-01 | 0.007 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.831565e-01 | 0.007 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.833458e-01 | 0.007 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.840068e-01 | 0.007 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.840068e-01 | 0.007 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.843504e-01 | 0.007 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.848495e-01 | 0.007 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.853021e-01 | 0.006 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.853021e-01 | 0.006 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.853021e-01 | 0.006 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.853021e-01 | 0.006 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.853021e-01 | 0.006 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.861662e-01 | 0.006 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.861662e-01 | 0.006 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.865390e-01 | 0.006 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.866108e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.866172e-01 | 0.006 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.871744e-01 | 0.006 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.871744e-01 | 0.006 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.871744e-01 | 0.006 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.877030e-01 | 0.005 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.877338e-01 | 0.005 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.879731e-01 | 0.005 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.888084e-01 | 0.005 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.888084e-01 | 0.005 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.888084e-01 | 0.005 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.888084e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.888084e-01 | 0.005 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.888084e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.888665e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.889588e-01 | 0.005 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.890729e-01 | 0.005 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.901615e-01 | 0.004 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.902342e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.902342e-01 | 0.004 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.907442e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.911855e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.911855e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.913804e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.914785e-01 | 0.004 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.914785e-01 | 0.004 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.914785e-01 | 0.004 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.914785e-01 | 0.004 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.914785e-01 | 0.004 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.914861e-01 | 0.004 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.916295e-01 | 0.004 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.919272e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.920311e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.921882e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.922550e-01 | 0.003 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.923481e-01 | 0.003 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.924195e-01 | 0.003 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.925643e-01 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.927208e-01 | 0.003 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.927679e-01 | 0.003 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.935118e-01 | 0.003 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.935118e-01 | 0.003 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.935118e-01 | 0.003 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.939618e-01 | 0.003 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.939751e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.939751e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.940837e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.941262e-01 | 0.003 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.943386e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.943713e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.943713e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.949575e-01 | 0.002 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.950601e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.950601e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.952616e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.952616e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.961102e-01 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.962366e-01 | 0.002 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.962391e-01 | 0.002 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.962391e-01 | 0.002 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.962391e-01 | 0.002 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.962391e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.962391e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.962391e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.962391e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.962773e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.967016e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.967185e-01 | 0.001 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.967185e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.967185e-01 | 0.001 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.967185e-01 | 0.001 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.967185e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.967185e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.970782e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.970782e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.971368e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.971554e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.971554e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.971554e-01 | 0.001 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.975018e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.975018e-01 | 0.001 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.975018e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.975018e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.977090e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.978202e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.978202e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.980982e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.980982e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.980982e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.980982e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.982958e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.983406e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.983511e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.983897e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.983897e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.985522e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.985951e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.986861e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.987368e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.988544e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.989069e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.990385e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.990385e-01 | 0.000 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.990385e-01 | 0.000 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.990771e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.991611e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.991611e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.991611e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.991611e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.991614e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.992111e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.992259e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.992681e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.993615e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.994411e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.995140e-01 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.995140e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.995631e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.995760e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.995760e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.995797e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.995917e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.995917e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.996156e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.996301e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996390e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997053e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.997521e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997521e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.997639e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.997937e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998070e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.998131e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998369e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.998577e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998624e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998650e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.998700e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998922e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999056e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999056e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999092e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999176e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999288e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999373e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999388e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999439e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999453e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999523e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999559e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999565e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999670e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999683e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999744e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999790e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999790e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999817e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999876e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999878e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999919e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999946e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999946e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999950e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999951e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999964e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999977e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999979e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999986e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999988e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999990e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999991e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999994e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999994e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999994e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999998e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999998e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 4.115042e-12 | 11.386 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.506040e-12 | 11.259 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.189793e-11 | 10.925 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.333911e-11 | 10.875 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.728631e-10 | 9.762 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.516231e-10 | 9.345 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.011877e-10 | 9.221 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.425443e-09 | 8.846 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.853367e-09 | 8.732 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.701223e-09 | 8.568 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.469714e-09 | 8.460 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.082138e-09 | 8.389 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.060514e-08 | 7.974 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.235332e-08 | 7.908 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.464888e-08 | 7.834 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.983378e-08 | 7.703 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.353643e-08 | 7.628 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.264240e-08 | 7.486 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.906129e-08 | 7.408 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.906129e-08 | 7.408 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.433970e-08 | 7.265 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.800168e-08 | 7.237 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.545784e-08 | 7.068 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.875726e-08 | 7.052 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.021507e-07 | 6.991 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.387943e-07 | 6.858 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.620211e-07 | 6.790 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.190097e-07 | 6.660 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.115786e-07 | 6.675 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.229033e-07 | 6.652 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.878539e-07 | 6.541 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.851808e-07 | 6.545 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.486975e-07 | 6.458 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.819956e-07 | 6.418 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.396491e-07 | 6.194 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.194412e-06 | 5.923 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.193013e-06 | 5.923 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.262270e-06 | 5.899 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.264010e-06 | 5.898 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.418585e-06 | 5.848 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.904015e-06 | 5.720 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.904015e-06 | 5.720 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.938084e-06 | 5.713 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.085417e-06 | 5.681 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.233159e-06 | 5.651 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.338666e-06 | 5.631 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.432969e-06 | 5.614 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.794037e-06 | 5.554 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.216919e-06 | 5.493 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.519820e-06 | 5.453 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.669930e-06 | 5.435 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.236604e-06 | 5.373 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.334199e-06 | 5.363 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.843044e-06 | 5.315 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.990807e-06 | 5.223 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.667265e-06 | 5.176 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.627379e-06 | 5.118 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.593991e-06 | 5.120 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.593991e-06 | 5.120 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.513210e-06 | 5.124 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.483536e-06 | 5.071 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.483536e-06 | 5.071 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.440181e-06 | 5.025 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.057924e-05 | 4.976 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.078212e-05 | 4.967 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.134855e-05 | 4.945 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.196729e-05 | 4.922 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.361723e-05 | 4.866 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.441731e-05 | 4.841 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.530463e-05 | 4.815 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.628118e-05 | 4.788 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.029445e-05 | 4.693 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.053759e-05 | 4.687 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.140489e-05 | 4.669 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.075784e-05 | 4.683 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.306395e-05 | 4.637 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.307159e-05 | 4.637 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.698401e-05 | 4.569 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.731448e-05 | 4.564 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.108870e-05 | 4.507 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.226236e-05 | 4.491 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.296745e-05 | 4.482 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.712019e-05 | 4.430 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.132762e-05 | 4.384 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.333487e-05 | 4.363 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.936257e-05 | 4.307 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.936257e-05 | 4.307 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.296523e-05 | 4.201 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.342821e-05 | 4.198 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.342821e-05 | 4.198 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.741570e-05 | 4.171 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.819054e-05 | 4.107 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.599217e-05 | 4.066 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.083968e-04 | 3.965 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.103855e-04 | 3.957 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.140260e-04 | 3.943 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.153373e-04 | 3.938 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.441807e-04 | 3.841 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.490972e-04 | 3.827 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.552396e-04 | 3.809 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.659877e-04 | 3.780 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.724643e-04 | 3.763 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.997327e-04 | 3.700 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.104553e-04 | 3.677 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.160066e-04 | 3.666 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.279906e-04 | 3.642 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.540524e-04 | 3.595 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.753332e-04 | 3.560 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.807707e-04 | 3.552 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.807707e-04 | 3.552 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.888491e-04 | 3.539 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.888491e-04 | 3.539 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.507284e-04 | 3.455 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.457771e-04 | 3.461 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.658878e-04 | 3.437 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.664186e-04 | 3.436 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.058391e-04 | 3.392 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.246546e-04 | 3.280 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.566070e-04 | 3.254 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.590128e-04 | 3.253 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.072949e-04 | 3.217 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.654183e-04 | 3.177 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.654183e-04 | 3.177 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.626129e-04 | 3.179 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.031773e-04 | 3.153 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.306104e-04 | 3.081 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.977610e-04 | 3.047 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.122515e-04 | 3.040 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.400566e-04 | 3.027 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.909514e-04 | 3.004 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.034419e-03 | 2.985 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.319101e-03 | 2.880 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.319101e-03 | 2.880 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.224431e-03 | 2.912 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.386433e-03 | 2.858 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.386433e-03 | 2.858 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.505699e-03 | 2.822 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.506874e-03 | 2.822 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.506874e-03 | 2.822 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.506874e-03 | 2.822 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.506874e-03 | 2.822 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.620695e-03 | 2.790 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.726572e-03 | 2.763 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.912178e-03 | 2.718 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.867922e-03 | 2.729 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.979141e-03 | 2.704 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.133230e-03 | 2.671 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.152102e-03 | 2.667 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.396749e-03 | 2.620 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.459841e-03 | 2.609 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.470128e-03 | 2.607 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.507028e-03 | 2.601 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.534041e-03 | 2.596 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.576367e-03 | 2.589 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.576367e-03 | 2.589 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.619393e-03 | 2.582 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.656081e-03 | 2.576 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.887683e-03 | 2.539 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.783769e-03 | 2.555 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.783769e-03 | 2.555 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.887683e-03 | 2.539 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.015046e-03 | 2.521 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.837675e-03 | 2.547 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.142280e-03 | 2.503 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.243843e-03 | 2.489 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.310869e-03 | 2.480 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.505412e-03 | 2.455 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.130395e-03 | 2.384 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.130395e-03 | 2.384 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.130395e-03 | 2.384 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.130395e-03 | 2.384 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.042345e-03 | 2.393 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.986150e-03 | 2.399 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.042345e-03 | 2.393 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.994786e-03 | 2.399 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.686744e-03 | 2.433 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.986150e-03 | 2.399 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.042345e-03 | 2.393 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.167214e-03 | 2.380 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.181108e-03 | 2.379 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.181108e-03 | 2.379 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.402674e-03 | 2.356 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.405504e-03 | 2.356 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.405504e-03 | 2.356 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.576938e-03 | 2.254 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.025033e-03 | 2.220 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.297695e-03 | 2.201 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.452064e-03 | 2.190 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.463509e-03 | 2.190 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.312538e-03 | 2.136 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.365366e-03 | 2.133 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.365366e-03 | 2.133 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.548645e-03 | 2.122 | 1 | 1 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.612990e-03 | 2.118 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.075067e-03 | 2.093 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.075067e-03 | 2.093 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.016624e-03 | 2.045 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.279723e-03 | 2.032 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.318561e-03 | 2.031 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.119912e-02 | 1.951 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.119912e-02 | 1.951 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.119912e-02 | 1.951 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.119912e-02 | 1.951 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.119912e-02 | 1.951 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.068493e-02 | 1.971 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.068493e-02 | 1.971 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.002268e-02 | 1.999 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.164475e-02 | 1.934 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.188220e-02 | 1.925 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.229373e-02 | 1.910 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.263430e-02 | 1.898 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.340120e-02 | 1.873 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.347330e-02 | 1.871 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.351373e-02 | 1.869 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.507004e-02 | 1.822 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.512598e-02 | 1.820 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.548196e-02 | 1.810 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.583471e-02 | 1.800 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.583471e-02 | 1.800 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.593369e-02 | 1.798 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.651601e-02 | 1.782 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.663913e-02 | 1.779 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.714247e-02 | 1.766 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.743381e-02 | 1.759 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.769266e-02 | 1.752 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.784587e-02 | 1.748 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.784587e-02 | 1.748 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.784587e-02 | 1.748 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.799688e-02 | 1.745 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.843513e-02 | 1.734 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.861774e-02 | 1.730 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.001531e-02 | 1.699 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.136530e-02 | 1.670 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.159571e-02 | 1.666 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.598746e-02 | 1.585 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.598746e-02 | 1.585 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.598746e-02 | 1.585 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.598746e-02 | 1.585 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.336600e-02 | 1.631 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.589263e-02 | 1.587 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.556066e-02 | 1.592 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.542533e-02 | 1.595 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.393010e-02 | 1.621 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.334936e-02 | 1.632 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.242862e-02 | 1.649 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.432103e-02 | 1.614 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.624577e-02 | 1.581 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.624577e-02 | 1.581 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.699496e-02 | 1.569 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.986957e-02 | 1.525 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.179506e-02 | 1.498 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.224234e-02 | 1.492 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.224234e-02 | 1.492 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.224234e-02 | 1.492 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.224234e-02 | 1.492 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.224234e-02 | 1.492 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.237026e-02 | 1.490 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.243617e-02 | 1.489 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.271495e-02 | 1.485 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.319678e-02 | 1.479 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.485467e-02 | 1.458 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.530074e-02 | 1.452 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.588980e-02 | 1.445 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.624612e-02 | 1.441 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.730885e-02 | 1.428 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.828506e-02 | 1.417 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.930401e-02 | 1.406 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.930401e-02 | 1.406 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.930401e-02 | 1.406 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.930401e-02 | 1.406 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.930401e-02 | 1.406 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.930401e-02 | 1.406 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.041597e-02 | 1.393 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.041597e-02 | 1.393 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.171278e-02 | 1.380 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.337358e-02 | 1.363 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.337358e-02 | 1.363 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.435631e-02 | 1.353 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.495053e-02 | 1.347 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.575461e-02 | 1.340 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.575461e-02 | 1.340 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.755784e-02 | 1.240 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.755784e-02 | 1.240 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.755784e-02 | 1.240 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.755784e-02 | 1.240 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.717749e-02 | 1.326 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.585979e-02 | 1.253 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.999613e-02 | 1.301 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.904887e-02 | 1.309 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.904887e-02 | 1.309 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.506197e-02 | 1.259 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.506197e-02 | 1.259 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.708214e-02 | 1.243 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.717749e-02 | 1.326 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.043822e-02 | 1.297 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.717749e-02 | 1.326 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.628828e-02 | 1.250 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.166133e-02 | 1.287 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.661350e-02 | 1.331 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.708214e-02 | 1.243 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.708214e-02 | 1.243 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.021489e-02 | 1.299 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.869236e-02 | 1.231 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 6.001486e-02 | 1.222 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.031529e-02 | 1.220 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.045389e-02 | 1.219 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.063968e-02 | 1.217 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.150073e-02 | 1.211 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.369682e-02 | 1.196 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.492408e-02 | 1.188 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.534054e-02 | 1.185 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.534054e-02 | 1.185 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.534054e-02 | 1.185 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.761507e-02 | 1.170 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.767616e-02 | 1.170 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.778409e-02 | 1.169 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.836634e-02 | 1.165 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.886005e-02 | 1.162 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.892561e-02 | 1.162 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.936431e-02 | 1.159 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.064413e-02 | 1.151 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.064413e-02 | 1.151 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.084437e-02 | 1.150 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.084437e-02 | 1.150 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.154517e-02 | 1.145 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.264794e-02 | 1.139 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.550079e-02 | 1.122 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.560271e-02 | 1.121 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 7.583970e-02 | 1.120 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 7.583970e-02 | 1.120 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 7.583970e-02 | 1.120 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 7.583970e-02 | 1.120 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.583970e-02 | 1.120 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 7.583970e-02 | 1.120 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 7.583970e-02 | 1.120 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.668731e-02 | 1.115 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.210969e-02 | 1.086 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.210969e-02 | 1.086 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 8.216052e-02 | 1.085 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.286114e-02 | 1.082 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.337334e-02 | 1.079 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.493446e-02 | 1.071 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.063546e-01 | 0.973 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.063546e-01 | 0.973 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.003405e-01 | 0.999 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.108222e-01 | 0.955 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.108222e-01 | 0.955 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.183558e-01 | 0.927 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.138144e-01 | 0.944 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.138144e-01 | 0.944 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.126931e-01 | 0.948 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.885665e-02 | 1.005 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.182882e-01 | 0.927 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.393400e-02 | 1.027 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.096403e-01 | 0.960 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.063546e-01 | 0.973 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.003405e-01 | 0.999 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.118190e-01 | 0.951 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.375894e-02 | 1.028 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.063546e-01 | 0.973 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.170482e-01 | 0.932 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.048355e-01 | 0.979 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.150771e-02 | 1.039 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.375894e-02 | 1.028 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.108222e-01 | 0.955 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.672265e-02 | 1.014 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.013879e-01 | 0.994 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.150771e-02 | 1.039 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.285819e-02 | 1.032 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.112364e-01 | 0.954 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.054794e-01 | 0.977 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.672265e-02 | 1.014 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.150771e-02 | 1.039 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.192641e-01 | 0.923 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.150771e-02 | 1.039 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.059955e-01 | 0.975 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.108222e-01 | 0.955 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.013879e-01 | 0.994 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.217091e-01 | 0.915 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.227443e-01 | 0.911 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.227443e-01 | 0.911 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.239312e-01 | 0.907 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.260427e-01 | 0.899 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.274401e-01 | 0.895 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.301446e-01 | 0.886 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.311971e-01 | 0.882 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.321595e-01 | 0.879 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.321595e-01 | 0.879 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.321595e-01 | 0.879 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.321595e-01 | 0.879 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.321595e-01 | 0.879 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.330262e-01 | 0.876 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.341174e-01 | 0.873 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.341174e-01 | 0.873 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.341174e-01 | 0.873 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.341174e-01 | 0.873 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.341439e-01 | 0.872 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.341439e-01 | 0.872 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.341439e-01 | 0.872 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.364742e-01 | 0.865 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.376610e-01 | 0.861 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.376610e-01 | 0.861 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.376610e-01 | 0.861 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.379664e-01 | 0.860 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.379664e-01 | 0.860 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.381947e-01 | 0.860 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.420949e-01 | 0.847 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.459319e-01 | 0.836 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.459319e-01 | 0.836 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.459319e-01 | 0.836 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.459319e-01 | 0.836 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.459319e-01 | 0.836 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.459319e-01 | 0.836 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.459961e-01 | 0.836 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.468468e-01 | 0.833 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.483905e-01 | 0.829 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.486598e-01 | 0.828 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.516452e-01 | 0.819 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.516452e-01 | 0.819 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.519694e-01 | 0.818 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.519694e-01 | 0.818 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.527199e-01 | 0.816 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.537796e-01 | 0.813 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.537796e-01 | 0.813 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.107119e-01 | 0.676 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.107119e-01 | 0.676 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.107119e-01 | 0.676 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.107119e-01 | 0.676 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.591922e-01 | 0.798 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.591922e-01 | 0.798 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.591922e-01 | 0.798 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.871185e-01 | 0.728 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.156477e-01 | 0.666 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.107365e-01 | 0.676 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.107365e-01 | 0.676 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.668120e-01 | 0.778 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.668120e-01 | 0.778 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.821430e-01 | 0.740 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.582774e-01 | 0.801 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.140827e-01 | 0.669 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.594695e-01 | 0.797 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.305970e-01 | 0.637 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.974415e-01 | 0.705 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.706081e-01 | 0.768 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.111798e-01 | 0.675 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.252132e-01 | 0.647 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.642647e-01 | 0.784 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.642647e-01 | 0.784 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.994510e-01 | 0.700 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 2.104052e-01 | 0.677 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.597568e-01 | 0.797 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.207891e-01 | 0.656 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.706081e-01 | 0.768 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.879276e-01 | 0.726 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.706081e-01 | 0.768 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.582774e-01 | 0.801 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.974415e-01 | 0.705 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.552528e-01 | 0.809 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.840266e-01 | 0.735 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.594695e-01 | 0.797 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.594695e-01 | 0.797 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.031269e-01 | 0.692 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.252132e-01 | 0.647 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.027159e-01 | 0.693 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.772505e-01 | 0.751 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.974415e-01 | 0.705 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.058283e-01 | 0.686 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.878383e-01 | 0.726 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.706081e-01 | 0.768 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.156477e-01 | 0.666 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.025749e-01 | 0.693 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.297774e-01 | 0.639 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.031269e-01 | 0.692 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 2.252132e-01 | 0.647 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.774762e-01 | 0.751 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.132603e-01 | 0.671 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.217589e-01 | 0.654 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.107119e-01 | 0.676 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.156477e-01 | 0.666 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.706081e-01 | 0.768 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.222118e-01 | 0.653 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.312064e-01 | 0.636 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.163181e-01 | 0.665 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.591922e-01 | 0.798 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.906970e-01 | 0.720 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.840266e-01 | 0.735 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.140827e-01 | 0.669 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.181099e-01 | 0.661 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.591922e-01 | 0.798 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.312064e-01 | 0.636 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.058283e-01 | 0.686 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.202883e-01 | 0.657 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.906970e-01 | 0.720 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.821430e-01 | 0.740 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.979157e-01 | 0.704 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.582774e-01 | 0.801 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.871185e-01 | 0.728 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.156477e-01 | 0.666 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.853622e-01 | 0.732 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.659655e-01 | 0.780 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.140827e-01 | 0.669 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.140827e-01 | 0.669 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.253972e-01 | 0.647 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.668120e-01 | 0.778 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.312064e-01 | 0.636 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.156477e-01 | 0.666 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.313080e-01 | 0.636 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.705820e-01 | 0.568 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.705820e-01 | 0.568 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.705820e-01 | 0.568 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.705820e-01 | 0.568 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.259141e-01 | 0.487 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.445279e-01 | 0.612 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.445279e-01 | 0.612 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.770518e-01 | 0.424 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.770518e-01 | 0.424 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.770518e-01 | 0.424 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.770518e-01 | 0.424 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.770518e-01 | 0.424 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.735420e-01 | 0.563 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.243129e-01 | 0.372 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.243129e-01 | 0.372 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.520165e-01 | 0.599 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.520165e-01 | 0.599 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.520165e-01 | 0.599 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.312542e-01 | 0.480 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.312542e-01 | 0.480 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.730810e-01 | 0.564 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.596590e-01 | 0.444 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.596590e-01 | 0.444 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.596590e-01 | 0.444 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.679911e-01 | 0.330 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.679911e-01 | 0.330 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.679911e-01 | 0.330 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.156533e-01 | 0.501 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.876053e-01 | 0.412 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.370140e-01 | 0.472 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.370140e-01 | 0.472 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.991977e-01 | 0.524 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.991977e-01 | 0.524 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.167601e-01 | 0.499 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.149992e-01 | 0.382 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.344025e-01 | 0.476 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.344025e-01 | 0.476 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.344025e-01 | 0.476 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.417638e-01 | 0.355 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.417638e-01 | 0.355 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.006198e-01 | 0.397 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.006198e-01 | 0.397 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.405420e-01 | 0.619 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.405420e-01 | 0.619 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.697711e-01 | 0.432 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.993513e-01 | 0.524 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.874235e-01 | 0.412 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.214781e-01 | 0.375 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.214781e-01 | 0.375 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.678369e-01 | 0.330 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.787133e-01 | 0.555 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.623983e-01 | 0.335 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.054136e-01 | 0.392 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.915961e-01 | 0.407 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.892944e-01 | 0.410 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.892944e-01 | 0.410 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.467497e-01 | 0.350 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.633953e-01 | 0.334 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.927171e-01 | 0.406 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.623983e-01 | 0.335 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.344025e-01 | 0.476 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.837233e-01 | 0.547 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.697711e-01 | 0.432 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.498079e-01 | 0.347 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.801976e-01 | 0.553 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.805705e-01 | 0.420 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.961370e-01 | 0.529 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.697711e-01 | 0.432 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.735420e-01 | 0.563 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.735420e-01 | 0.563 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.678369e-01 | 0.330 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.107523e-01 | 0.508 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.338640e-01 | 0.363 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.709132e-01 | 0.431 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.770518e-01 | 0.424 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.243129e-01 | 0.372 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.596590e-01 | 0.444 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.540505e-01 | 0.595 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.417638e-01 | 0.355 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.214781e-01 | 0.375 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.499909e-01 | 0.456 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.558973e-01 | 0.449 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.063338e-01 | 0.391 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.312542e-01 | 0.480 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.583348e-01 | 0.446 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.937432e-01 | 0.532 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.243129e-01 | 0.372 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.678369e-01 | 0.330 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.678369e-01 | 0.330 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.730810e-01 | 0.564 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.417638e-01 | 0.355 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.420845e-01 | 0.354 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.623983e-01 | 0.335 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.679911e-01 | 0.330 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.679911e-01 | 0.330 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.149992e-01 | 0.382 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.598525e-01 | 0.585 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.671966e-01 | 0.331 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.694334e-01 | 0.570 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.547297e-01 | 0.594 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.293022e-01 | 0.482 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.170562e-01 | 0.499 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.973462e-01 | 0.401 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.520855e-01 | 0.453 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.644798e-01 | 0.578 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 3.596590e-01 | 0.444 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.433854e-01 | 0.353 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.633953e-01 | 0.334 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.627858e-01 | 0.580 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.705820e-01 | 0.568 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.259141e-01 | 0.487 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.770518e-01 | 0.424 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.770518e-01 | 0.424 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.735420e-01 | 0.563 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.025037e-01 | 0.519 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.243129e-01 | 0.372 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.730810e-01 | 0.564 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.943186e-01 | 0.531 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 4.679911e-01 | 0.330 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.679911e-01 | 0.330 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.876053e-01 | 0.412 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.991977e-01 | 0.524 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.991977e-01 | 0.524 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.837233e-01 | 0.547 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.417638e-01 | 0.355 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.417638e-01 | 0.355 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.678369e-01 | 0.330 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.398530e-01 | 0.357 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.612511e-01 | 0.336 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.028520e-01 | 0.519 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.695800e-01 | 0.432 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.140036e-01 | 0.503 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.417638e-01 | 0.355 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.417638e-01 | 0.355 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.697711e-01 | 0.432 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.367080e-01 | 0.626 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.596590e-01 | 0.444 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 4.417638e-01 | 0.355 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.445279e-01 | 0.612 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.735420e-01 | 0.563 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.149992e-01 | 0.382 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.916887e-01 | 0.407 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.943186e-01 | 0.531 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.398530e-01 | 0.357 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.445279e-01 | 0.612 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.445279e-01 | 0.612 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.312542e-01 | 0.480 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 4.679911e-01 | 0.330 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.644798e-01 | 0.578 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.149992e-01 | 0.382 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.874235e-01 | 0.412 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.678369e-01 | 0.330 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.216783e-01 | 0.375 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.666946e-01 | 0.436 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.676356e-01 | 0.435 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.149992e-01 | 0.382 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.149992e-01 | 0.382 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.678369e-01 | 0.330 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.918954e-01 | 0.535 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.224953e-01 | 0.374 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.426429e-01 | 0.354 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.295348e-01 | 0.482 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.295348e-01 | 0.482 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.259141e-01 | 0.487 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.445279e-01 | 0.612 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.735420e-01 | 0.563 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.735420e-01 | 0.563 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.312542e-01 | 0.480 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.679911e-01 | 0.330 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.370140e-01 | 0.472 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.563122e-01 | 0.591 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.988015e-01 | 0.525 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.678369e-01 | 0.330 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 4.678369e-01 | 0.330 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.623983e-01 | 0.335 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.293022e-01 | 0.482 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.152042e-01 | 0.501 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.905407e-01 | 0.408 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.395130e-01 | 0.621 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.801397e-01 | 0.420 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.874235e-01 | 0.412 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.671966e-01 | 0.331 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.687968e-01 | 0.571 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.697711e-01 | 0.432 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.185445e-01 | 0.497 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.653439e-01 | 0.576 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.540318e-01 | 0.343 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.102294e-01 | 0.508 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.923910e-01 | 0.406 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.705820e-01 | 0.568 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.445279e-01 | 0.612 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.770518e-01 | 0.424 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.735420e-01 | 0.563 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.943186e-01 | 0.531 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.398530e-01 | 0.357 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.521294e-01 | 0.345 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.904984e-01 | 0.537 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.526381e-01 | 0.598 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.876053e-01 | 0.412 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.943186e-01 | 0.531 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.540505e-01 | 0.595 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.562540e-01 | 0.591 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.025037e-01 | 0.519 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.644798e-01 | 0.578 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.371171e-01 | 0.359 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 2.705820e-01 | 0.568 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.445279e-01 | 0.612 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.025037e-01 | 0.519 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.243129e-01 | 0.372 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.679911e-01 | 0.330 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.876053e-01 | 0.412 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.583348e-01 | 0.446 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.149992e-01 | 0.382 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.688411e-01 | 0.433 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.433714e-01 | 0.614 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.923910e-01 | 0.406 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 4.679911e-01 | 0.330 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.876053e-01 | 0.412 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.697711e-01 | 0.432 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.678369e-01 | 0.330 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.307603e-01 | 0.366 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.596590e-01 | 0.444 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.460835e-01 | 0.609 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.761612e-01 | 0.559 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.735420e-01 | 0.563 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.167601e-01 | 0.499 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.243129e-01 | 0.372 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.718914e-01 | 0.326 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.744602e-01 | 0.324 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.748217e-01 | 0.323 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.778212e-01 | 0.321 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.821340e-01 | 0.317 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.821818e-01 | 0.317 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.823832e-01 | 0.317 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.823832e-01 | 0.317 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.882922e-01 | 0.311 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.931695e-01 | 0.307 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.931695e-01 | 0.307 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.931695e-01 | 0.307 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.931695e-01 | 0.307 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.931695e-01 | 0.307 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.931695e-01 | 0.307 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.942602e-01 | 0.306 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.942602e-01 | 0.306 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.975173e-01 | 0.303 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.977069e-01 | 0.303 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.020072e-01 | 0.299 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.020072e-01 | 0.299 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.020072e-01 | 0.299 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.020072e-01 | 0.299 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.074727e-01 | 0.295 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.074727e-01 | 0.295 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.074727e-01 | 0.295 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.074727e-01 | 0.295 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.074727e-01 | 0.295 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.083578e-01 | 0.294 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.083578e-01 | 0.294 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.083578e-01 | 0.294 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.083578e-01 | 0.294 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.083578e-01 | 0.294 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.115529e-01 | 0.291 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.119104e-01 | 0.291 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.168235e-01 | 0.287 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.177238e-01 | 0.286 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.177238e-01 | 0.286 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.177238e-01 | 0.286 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.177238e-01 | 0.286 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.177238e-01 | 0.286 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.177391e-01 | 0.286 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.212423e-01 | 0.283 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.238114e-01 | 0.281 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.238114e-01 | 0.281 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.260041e-01 | 0.279 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.266137e-01 | 0.279 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.318284e-01 | 0.274 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.400645e-01 | 0.268 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.400645e-01 | 0.268 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.400645e-01 | 0.268 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.402646e-01 | 0.267 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.414722e-01 | 0.266 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.414722e-01 | 0.266 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.414722e-01 | 0.266 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.414722e-01 | 0.266 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.414722e-01 | 0.266 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.417466e-01 | 0.266 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.456638e-01 | 0.263 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.456638e-01 | 0.263 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.456638e-01 | 0.263 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.456638e-01 | 0.263 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.456638e-01 | 0.263 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.456638e-01 | 0.263 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.456638e-01 | 0.263 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.456638e-01 | 0.263 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.456638e-01 | 0.263 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.456638e-01 | 0.263 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.456638e-01 | 0.263 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.456638e-01 | 0.263 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.544411e-01 | 0.256 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.556782e-01 | 0.255 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.584535e-01 | 0.253 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.643956e-01 | 0.248 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.643956e-01 | 0.248 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.643956e-01 | 0.248 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.643956e-01 | 0.248 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.681651e-01 | 0.246 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.681651e-01 | 0.246 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.711762e-01 | 0.243 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.733218e-01 | 0.242 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.744918e-01 | 0.241 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.763920e-01 | 0.239 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.787982e-01 | 0.237 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.787982e-01 | 0.237 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 5.801411e-01 | 0.236 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 5.801411e-01 | 0.236 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.801411e-01 | 0.236 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.801411e-01 | 0.236 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.801411e-01 | 0.236 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.801411e-01 | 0.236 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.801411e-01 | 0.236 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.801411e-01 | 0.236 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.834682e-01 | 0.234 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.863666e-01 | 0.232 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.863666e-01 | 0.232 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.863666e-01 | 0.232 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.864823e-01 | 0.232 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.864823e-01 | 0.232 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.864823e-01 | 0.232 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.881810e-01 | 0.230 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.910671e-01 | 0.228 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.938661e-01 | 0.226 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.951679e-01 | 0.225 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.966510e-01 | 0.224 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.966510e-01 | 0.224 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.012388e-01 | 0.221 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.031463e-01 | 0.220 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.062796e-01 | 0.217 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.070677e-01 | 0.217 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.075491e-01 | 0.216 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.077275e-01 | 0.216 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.077275e-01 | 0.216 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.077275e-01 | 0.216 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.079203e-01 | 0.216 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.083099e-01 | 0.216 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.095792e-01 | 0.215 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.108649e-01 | 0.214 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.108649e-01 | 0.214 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.108649e-01 | 0.214 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.120040e-01 | 0.213 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.120040e-01 | 0.213 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.120040e-01 | 0.213 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.120040e-01 | 0.213 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.120040e-01 | 0.213 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.120040e-01 | 0.213 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.120040e-01 | 0.213 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.120040e-01 | 0.213 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.120040e-01 | 0.213 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.120040e-01 | 0.213 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.120040e-01 | 0.213 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.120040e-01 | 0.213 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.120040e-01 | 0.213 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.157834e-01 | 0.211 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.157834e-01 | 0.211 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.173450e-01 | 0.209 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.267099e-01 | 0.203 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.268939e-01 | 0.203 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.273800e-01 | 0.202 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.273800e-01 | 0.202 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.273800e-01 | 0.202 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.274786e-01 | 0.202 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.274786e-01 | 0.202 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.274786e-01 | 0.202 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.281316e-01 | 0.202 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.281316e-01 | 0.202 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.281316e-01 | 0.202 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.338386e-01 | 0.198 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.338386e-01 | 0.198 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.381832e-01 | 0.195 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.414506e-01 | 0.193 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.414506e-01 | 0.193 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.414506e-01 | 0.193 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.414506e-01 | 0.193 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.414506e-01 | 0.193 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.414506e-01 | 0.193 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.414506e-01 | 0.193 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.414506e-01 | 0.193 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.414506e-01 | 0.193 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.414506e-01 | 0.193 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.426269e-01 | 0.192 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.434055e-01 | 0.192 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.434055e-01 | 0.192 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.438604e-01 | 0.191 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.462133e-01 | 0.190 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.462133e-01 | 0.190 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.462133e-01 | 0.190 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.462133e-01 | 0.190 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.476999e-01 | 0.189 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.476999e-01 | 0.189 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.476999e-01 | 0.189 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.476999e-01 | 0.189 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 6.476999e-01 | 0.189 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.476999e-01 | 0.189 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.569789e-01 | 0.182 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.571871e-01 | 0.182 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.573814e-01 | 0.182 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.573814e-01 | 0.182 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.589377e-01 | 0.181 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.589377e-01 | 0.181 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 6.589377e-01 | 0.181 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.589377e-01 | 0.181 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.589377e-01 | 0.181 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.651762e-01 | 0.177 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.664417e-01 | 0.176 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.664417e-01 | 0.176 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 6.664417e-01 | 0.176 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.664417e-01 | 0.176 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.664417e-01 | 0.176 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.664417e-01 | 0.176 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.686640e-01 | 0.175 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.686640e-01 | 0.175 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.686640e-01 | 0.175 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.686640e-01 | 0.175 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.686640e-01 | 0.175 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.686640e-01 | 0.175 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.686640e-01 | 0.175 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 6.686640e-01 | 0.175 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.686640e-01 | 0.175 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.686640e-01 | 0.175 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.701599e-01 | 0.174 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.701599e-01 | 0.174 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.701599e-01 | 0.174 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.705520e-01 | 0.174 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.705520e-01 | 0.174 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.706411e-01 | 0.174 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.728295e-01 | 0.172 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.739752e-01 | 0.171 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.739752e-01 | 0.171 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.758631e-01 | 0.170 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.769367e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.787002e-01 | 0.168 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.817249e-01 | 0.166 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.817249e-01 | 0.166 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.833694e-01 | 0.165 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.843697e-01 | 0.165 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.843697e-01 | 0.165 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.850625e-01 | 0.164 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.885183e-01 | 0.162 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 6.938134e-01 | 0.159 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.938134e-01 | 0.159 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.938134e-01 | 0.159 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.938134e-01 | 0.159 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 6.938134e-01 | 0.159 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.938134e-01 | 0.159 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.938134e-01 | 0.159 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.938134e-01 | 0.159 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.938134e-01 | 0.159 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.938134e-01 | 0.159 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.958323e-01 | 0.157 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.003539e-01 | 0.155 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.014995e-01 | 0.154 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.014995e-01 | 0.154 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.014995e-01 | 0.154 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.014995e-01 | 0.154 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.014995e-01 | 0.154 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.014995e-01 | 0.154 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.014995e-01 | 0.154 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.025688e-01 | 0.153 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.025688e-01 | 0.153 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.025688e-01 | 0.153 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.025688e-01 | 0.153 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.040266e-01 | 0.152 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.115201e-01 | 0.148 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.161304e-01 | 0.145 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.161304e-01 | 0.145 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.161304e-01 | 0.145 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.161304e-01 | 0.145 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.170554e-01 | 0.144 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.170554e-01 | 0.144 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.170554e-01 | 0.144 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.170554e-01 | 0.144 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.170554e-01 | 0.144 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.170554e-01 | 0.144 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.170554e-01 | 0.144 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.170554e-01 | 0.144 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.170554e-01 | 0.144 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.170554e-01 | 0.144 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.170554e-01 | 0.144 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.178489e-01 | 0.144 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.178489e-01 | 0.144 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.178489e-01 | 0.144 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.190121e-01 | 0.143 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.205555e-01 | 0.142 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.205555e-01 | 0.142 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.205833e-01 | 0.142 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.285582e-01 | 0.138 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.292078e-01 | 0.137 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.334377e-01 | 0.135 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.334377e-01 | 0.135 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.334377e-01 | 0.135 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.334377e-01 | 0.135 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.334377e-01 | 0.135 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.334377e-01 | 0.135 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.353932e-01 | 0.133 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.353932e-01 | 0.133 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.367488e-01 | 0.133 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.379031e-01 | 0.132 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.381228e-01 | 0.132 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.381228e-01 | 0.132 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.385343e-01 | 0.132 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.385343e-01 | 0.132 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.385343e-01 | 0.132 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.385343e-01 | 0.132 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.385343e-01 | 0.132 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.385343e-01 | 0.132 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.385343e-01 | 0.132 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.385343e-01 | 0.132 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.385343e-01 | 0.132 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.385343e-01 | 0.132 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.385343e-01 | 0.132 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.418071e-01 | 0.130 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.418071e-01 | 0.130 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.418071e-01 | 0.130 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.418071e-01 | 0.130 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.418071e-01 | 0.130 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.438737e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.438737e-01 | 0.129 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.482870e-01 | 0.126 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.482870e-01 | 0.126 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.482870e-01 | 0.126 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.482870e-01 | 0.126 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.518630e-01 | 0.124 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.528406e-01 | 0.123 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.539354e-01 | 0.123 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.539354e-01 | 0.123 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.548779e-01 | 0.122 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.549160e-01 | 0.122 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.583839e-01 | 0.120 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.583839e-01 | 0.120 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.583839e-01 | 0.120 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.583839e-01 | 0.120 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.583839e-01 | 0.120 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.583839e-01 | 0.120 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.583839e-01 | 0.120 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.583839e-01 | 0.120 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.583839e-01 | 0.120 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.583839e-01 | 0.120 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.583839e-01 | 0.120 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.583839e-01 | 0.120 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.624194e-01 | 0.118 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.624194e-01 | 0.118 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.624194e-01 | 0.118 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.624194e-01 | 0.118 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.624194e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.656008e-01 | 0.116 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.656008e-01 | 0.116 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.677994e-01 | 0.115 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.758580e-01 | 0.110 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.758580e-01 | 0.110 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.758580e-01 | 0.110 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.758580e-01 | 0.110 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.761996e-01 | 0.110 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.767277e-01 | 0.110 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.767277e-01 | 0.110 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.767277e-01 | 0.110 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.767277e-01 | 0.110 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.767277e-01 | 0.110 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.767277e-01 | 0.110 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.767277e-01 | 0.110 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.767277e-01 | 0.110 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.767277e-01 | 0.110 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.828864e-01 | 0.106 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.828864e-01 | 0.106 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.860468e-01 | 0.105 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.875785e-01 | 0.104 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.875785e-01 | 0.104 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.875785e-01 | 0.104 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.875785e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.875785e-01 | 0.104 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.875785e-01 | 0.104 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.886267e-01 | 0.103 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.886267e-01 | 0.103 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.886267e-01 | 0.103 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.886267e-01 | 0.103 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.936798e-01 | 0.100 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 7.936798e-01 | 0.100 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.936798e-01 | 0.100 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.936798e-01 | 0.100 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.936798e-01 | 0.100 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 7.936798e-01 | 0.100 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 7.936798e-01 | 0.100 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 7.936798e-01 | 0.100 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.979105e-01 | 0.098 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.979105e-01 | 0.098 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.979105e-01 | 0.098 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.990247e-01 | 0.097 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.007497e-01 | 0.097 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.012528e-01 | 0.096 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.032236e-01 | 0.095 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.078184e-01 | 0.093 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.092830e-01 | 0.092 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.093458e-01 | 0.092 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.093458e-01 | 0.092 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.093458e-01 | 0.092 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.093458e-01 | 0.092 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.093458e-01 | 0.092 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.093458e-01 | 0.092 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.093458e-01 | 0.092 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.093458e-01 | 0.092 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.122514e-01 | 0.090 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.122514e-01 | 0.090 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.136739e-01 | 0.090 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.158103e-01 | 0.088 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.173134e-01 | 0.088 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.183402e-01 | 0.087 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.217846e-01 | 0.085 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.231563e-01 | 0.085 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.231563e-01 | 0.085 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.235456e-01 | 0.084 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.238231e-01 | 0.084 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.238231e-01 | 0.084 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.238231e-01 | 0.084 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.238231e-01 | 0.084 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.238231e-01 | 0.084 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.238231e-01 | 0.084 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.238231e-01 | 0.084 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.238231e-01 | 0.084 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.295081e-01 | 0.081 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.334886e-01 | 0.079 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.334886e-01 | 0.079 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.334886e-01 | 0.079 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.334886e-01 | 0.079 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.334886e-01 | 0.079 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.334886e-01 | 0.079 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.334886e-01 | 0.079 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.334886e-01 | 0.079 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.334886e-01 | 0.079 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.334886e-01 | 0.079 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.372019e-01 | 0.077 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.372019e-01 | 0.077 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.372019e-01 | 0.077 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.372019e-01 | 0.077 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.372019e-01 | 0.077 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.372019e-01 | 0.077 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.372019e-01 | 0.077 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.431822e-01 | 0.074 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.432724e-01 | 0.074 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.432724e-01 | 0.074 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.432724e-01 | 0.074 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.432724e-01 | 0.074 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.433049e-01 | 0.074 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.434336e-01 | 0.074 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.434336e-01 | 0.074 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.485757e-01 | 0.071 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.495654e-01 | 0.071 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.495654e-01 | 0.071 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.495654e-01 | 0.071 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.495654e-01 | 0.071 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.495654e-01 | 0.071 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.502611e-01 | 0.070 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.513910e-01 | 0.070 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.513910e-01 | 0.070 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.525314e-01 | 0.069 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.584038e-01 | 0.066 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.589934e-01 | 0.066 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.608016e-01 | 0.065 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.609907e-01 | 0.065 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.609907e-01 | 0.065 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.609907e-01 | 0.065 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.609907e-01 | 0.065 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.609907e-01 | 0.065 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.609907e-01 | 0.065 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.609907e-01 | 0.065 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.609907e-01 | 0.065 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.609907e-01 | 0.065 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.609907e-01 | 0.065 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.612888e-01 | 0.065 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.624558e-01 | 0.064 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.662526e-01 | 0.062 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.688410e-01 | 0.061 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.688410e-01 | 0.061 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.688410e-01 | 0.061 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.695674e-01 | 0.061 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.695674e-01 | 0.061 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.696844e-01 | 0.061 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.696844e-01 | 0.061 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.696844e-01 | 0.061 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.715489e-01 | 0.060 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.715489e-01 | 0.060 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.715489e-01 | 0.060 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.715489e-01 | 0.060 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.715489e-01 | 0.060 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.715489e-01 | 0.060 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.715489e-01 | 0.060 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.715489e-01 | 0.060 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.731805e-01 | 0.059 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.731805e-01 | 0.059 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.731805e-01 | 0.059 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.773894e-01 | 0.057 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.773894e-01 | 0.057 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.797887e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.797887e-01 | 0.056 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.797887e-01 | 0.056 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.808489e-01 | 0.055 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.813057e-01 | 0.055 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.813057e-01 | 0.055 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.813057e-01 | 0.055 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.813057e-01 | 0.055 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.813057e-01 | 0.055 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.813057e-01 | 0.055 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.813057e-01 | 0.055 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.813057e-01 | 0.055 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.845082e-01 | 0.053 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.847763e-01 | 0.053 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.847763e-01 | 0.053 | 0 | 0 |
| Translation | R-HSA-72766 | 8.856416e-01 | 0.053 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.899827e-01 | 0.051 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.903220e-01 | 0.050 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.903220e-01 | 0.050 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.903220e-01 | 0.050 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.903220e-01 | 0.050 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.903220e-01 | 0.050 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.903220e-01 | 0.050 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.903220e-01 | 0.050 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.903220e-01 | 0.050 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.903220e-01 | 0.050 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 8.903220e-01 | 0.050 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.903220e-01 | 0.050 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.917491e-01 | 0.050 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.917491e-01 | 0.050 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.917491e-01 | 0.050 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.917491e-01 | 0.050 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.918899e-01 | 0.050 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.920923e-01 | 0.050 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.920923e-01 | 0.050 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.937091e-01 | 0.049 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.978105e-01 | 0.047 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.983280e-01 | 0.047 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.983280e-01 | 0.047 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.983280e-01 | 0.047 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.983280e-01 | 0.047 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.983280e-01 | 0.047 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.983280e-01 | 0.047 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.986539e-01 | 0.046 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.986539e-01 | 0.046 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.986539e-01 | 0.046 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.020238e-01 | 0.045 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.026461e-01 | 0.044 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.063532e-01 | 0.043 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.063532e-01 | 0.043 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.063532e-01 | 0.043 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.063532e-01 | 0.043 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.063532e-01 | 0.043 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.063532e-01 | 0.043 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.066127e-01 | 0.043 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.066127e-01 | 0.043 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.067688e-01 | 0.043 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.067688e-01 | 0.043 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.075851e-01 | 0.042 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.079245e-01 | 0.042 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.084348e-01 | 0.042 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.084348e-01 | 0.042 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.091914e-01 | 0.041 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.100812e-01 | 0.041 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.103820e-01 | 0.041 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.103820e-01 | 0.041 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.113089e-01 | 0.040 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.120755e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.134681e-01 | 0.039 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.134681e-01 | 0.039 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.134681e-01 | 0.039 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.134681e-01 | 0.039 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.134681e-01 | 0.039 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.143928e-01 | 0.039 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.158940e-01 | 0.038 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.158940e-01 | 0.038 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.176765e-01 | 0.037 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.180476e-01 | 0.037 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.200428e-01 | 0.036 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.200428e-01 | 0.036 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.200428e-01 | 0.036 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.200428e-01 | 0.036 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.200428e-01 | 0.036 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.210863e-01 | 0.036 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.210863e-01 | 0.036 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.210863e-01 | 0.036 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.210863e-01 | 0.036 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.259756e-01 | 0.033 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.259756e-01 | 0.033 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.259756e-01 | 0.033 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.261184e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.261184e-01 | 0.033 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.305779e-01 | 0.031 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.317326e-01 | 0.031 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.317326e-01 | 0.031 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.336906e-01 | 0.030 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.349085e-01 | 0.029 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.349085e-01 | 0.029 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.365947e-01 | 0.028 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.367911e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.369205e-01 | 0.028 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.369205e-01 | 0.028 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.369205e-01 | 0.028 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.369205e-01 | 0.028 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.379307e-01 | 0.028 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.389823e-01 | 0.027 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.389823e-01 | 0.027 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.389823e-01 | 0.027 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.397609e-01 | 0.027 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.417144e-01 | 0.026 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.417144e-01 | 0.026 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.428132e-01 | 0.026 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.440749e-01 | 0.025 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.461443e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.461443e-01 | 0.024 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.461443e-01 | 0.024 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.461443e-01 | 0.024 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.464145e-01 | 0.024 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.472011e-01 | 0.024 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.479569e-01 | 0.023 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.481057e-01 | 0.023 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.497991e-01 | 0.022 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.502378e-01 | 0.022 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.502378e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.522541e-01 | 0.021 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.529790e-01 | 0.021 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.529790e-01 | 0.021 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.529790e-01 | 0.021 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.540203e-01 | 0.020 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.540203e-01 | 0.020 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.540203e-01 | 0.020 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.550846e-01 | 0.020 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.562771e-01 | 0.019 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.565589e-01 | 0.019 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.575155e-01 | 0.019 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.575155e-01 | 0.019 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.575155e-01 | 0.019 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.575155e-01 | 0.019 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.575155e-01 | 0.019 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.587705e-01 | 0.018 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.592085e-01 | 0.018 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.593197e-01 | 0.018 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.593197e-01 | 0.018 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.593197e-01 | 0.018 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.593428e-01 | 0.018 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.593428e-01 | 0.018 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.607452e-01 | 0.017 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.607452e-01 | 0.017 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.607452e-01 | 0.017 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.607452e-01 | 0.017 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.607452e-01 | 0.017 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.611134e-01 | 0.017 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.611134e-01 | 0.017 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.615058e-01 | 0.017 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.633386e-01 | 0.016 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.637296e-01 | 0.016 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.637296e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.637296e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.637296e-01 | 0.016 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.637296e-01 | 0.016 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.654435e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.656512e-01 | 0.015 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.664873e-01 | 0.015 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.664873e-01 | 0.015 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.664873e-01 | 0.015 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.669343e-01 | 0.015 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.690354e-01 | 0.014 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.690354e-01 | 0.014 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.690354e-01 | 0.014 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.690354e-01 | 0.014 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.704085e-01 | 0.013 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.704085e-01 | 0.013 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.704085e-01 | 0.013 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.704085e-01 | 0.013 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.704085e-01 | 0.013 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.706372e-01 | 0.013 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.713118e-01 | 0.013 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.713899e-01 | 0.013 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.713899e-01 | 0.013 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.733885e-01 | 0.012 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.735655e-01 | 0.012 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.735655e-01 | 0.012 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.735655e-01 | 0.012 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.741145e-01 | 0.011 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.743636e-01 | 0.011 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.755758e-01 | 0.011 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.755758e-01 | 0.011 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.755758e-01 | 0.011 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.774334e-01 | 0.010 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.774334e-01 | 0.010 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.774334e-01 | 0.010 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.791497e-01 | 0.009 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.791497e-01 | 0.009 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.798776e-01 | 0.009 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.802276e-01 | 0.009 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.806057e-01 | 0.009 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.810479e-01 | 0.008 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.811945e-01 | 0.008 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.815219e-01 | 0.008 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.822010e-01 | 0.008 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.827338e-01 | 0.008 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.827768e-01 | 0.008 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.835550e-01 | 0.007 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.835550e-01 | 0.007 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.835550e-01 | 0.007 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.842486e-01 | 0.007 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.843581e-01 | 0.007 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.848061e-01 | 0.007 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.859242e-01 | 0.006 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.859620e-01 | 0.006 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.868541e-01 | 0.006 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.870301e-01 | 0.006 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.880901e-01 | 0.005 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.884437e-01 | 0.005 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.885379e-01 | 0.005 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.892990e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.904258e-01 | 0.004 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.905498e-01 | 0.004 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.908255e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.912980e-01 | 0.004 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.915476e-01 | 0.004 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.931148e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.932692e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.932692e-01 | 0.003 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.936390e-01 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.941232e-01 | 0.003 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.941232e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.949840e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.949840e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.953660e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.953660e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.956615e-01 | 0.002 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.957189e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.960305e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.963461e-01 | 0.002 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.968057e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.969172e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.969609e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.973385e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.973385e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.973491e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.976632e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.979016e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.979500e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.980031e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.980615e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.982676e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.983457e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.985882e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.987956e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.990020e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.990070e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.991751e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.993642e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.994100e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.994596e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.995236e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.995252e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.995878e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.995878e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997897e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998206e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998343e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998794e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998968e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999183e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999244e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999308e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999361e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999628e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999721e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999756e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999764e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999773e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999793e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999796e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999806e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999835e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999837e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999913e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999917e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999947e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999950e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999954e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999976e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999976e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999977e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999977e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999978e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999990e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999998e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |